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Abstract
In various conditions like hypoxia, ischemia and brain injury, the extracellular 
levels of the important neuromodulator, adenosine are increased. This study has 
considered the effects of adenosine in the CAl area of hippocampus and its 
interactions with metabotropic glutamate receptors, nitric oxide and free radicals. 
Single and paired-pulse stimuli have been applied to the Schaffer collateral fibers 
in stratum radiatum and extracellular recordings were made from the CAl 
pyramidal cell layer of hippocampal slices. We have examined excitatory 
postsynaptic potentials and paired-pulse interactions to obtain more information 
about the site and mechanism of these interactions.
The results show suppression of adenosine sensitivity by metabotropic glutamate 
receptors, explained by a selectively reduced responsiveness to Ai receptor 
stimulation, which does not involve any facilitation of A2A adenosine receptors, 
since it can be obtained in the absence of endogenous adenosine and is not 
prevented by the A2A receptor blocker ZM241385.
The glutamate receptors involved aie of the group 1 class since the suppression of 
adenosine sensitivity is produced by ACPD and the group 1 selective compound 
DHPG. Furthermore, the effects of DHPG could be prevented by LY367385, a 
selective antagonist at the mGluia subtype of group 1 receptors. The selective 
antagonist at mGlug receptors, SIB 1893, did not prevent the suppression of 
adenosine sensitivity by DHPG. Blockade of the DHPG/adenosine interaction was 
also obtained by superfusion with the protein kinase C inhibitor chelerythrine.
n
Since the suppression of adenosine responses by metabotropic receptor agonists 
was seen in the paired-pulse paradigm, we conclude that the observed interactions 
occur at the level of the presynaptic terminals. The interaction with adenosine 
receptors is not specific, but applies also to a suppression of responses mediated 
by the GABAb receptor agonist baclofen.
In conclusion, activation of the mGluia subtype of receptor can suppress responses 
mediated via adenosine A l receptors, probably by activating protein kinase C. 
Since the changes induced by metabotropic glutamate receptor agonists last for at 
least 60 minutes, the data also imply that these interactions could play an 
important role in changes of synaptic function long after even transient increases 
of glutamate release in the CNS.
The second part of this study investigated the interaction between adenosine and 
nitric oxide. Activation of NMDA receptors has been shown to suppress neuronal 
responses to adenosine in hippocampal slices. Since NMDA receptor activation is 
known to lead to the generation of nitric oxide (NO), we have now examined 
whether NO is able to modify neuronal responses to adenosine and mediate the 
actions of NMDA.
The superfusion of the NO donor, S-nitroso-N-acetylpenicillamine (SNAP) 
induced a long-lasting potentiation of fEPSP slope and reduced responses to 
adenosine. The guanylate cyclase inhibitor ODQ prevented the inhibitory effects 
of SNAP on adenosine responses and also prevented the SNAP-induced LTP, 
suggesting that the action of NO is mediated through cyclic GMP.
The third part of this study was to examine the effects of another free radical 
species, superoxide on adenosine responses and fEPSPs to determine whether the
m
suppression effects on adenosine were specific for NO. Superfusion of a xanthine 
/ xanthine oxidase mixture (X/XO) induced LTP and significantly suppressed 
responses to adenosine. ODQ and superoxide dismutase (SOD) prevented the 
inhibitory effects of X/XO on adenosine responses and their induction of LTP, 
suggesting that oxygen free radieals are involved, probably due to formation of 
peroxynitrite. The effects of ODQ and SOD on the interaction between adenosine 
and NMDA indicate that cGMP does not mediate this interaction but oxygen free 
radicals might contribute. Paired-pulse interactions showed that the suppression of 
inhibitory effects of adenosine by NO and X/XO are happening presynaptically. 
Overall we have demonstrated several factors which can modify adenosine 
sensitivity in the hippocampus. These interactions may contribute to the 
physiological and pathological regulation of neuronal excitability and plasticity.
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1. Introduction
There are several experimental and pathological situations, such as hypoxia or 
ischemia, in which there is increased release of glutamate from cells. In many of 
these circumstances, there is also an increase in the extracellular levels of 
adenosine (Stone & Simmonds, 1991; Latini & Pedata, 2001) which can protect 
neurons from damage. Interactions between adenosine receptors and ionotropic 
excitatory amino-acid transmission (via NMDA receptors) have previously been 
reported from our laboratory (Bartrup & Stone, 1988, 1990; Nikbakht & Stone, 
2001), and there have been reports of interactions between adenosine and mGluRs 
(de Mendonca & Ribeiro, 1997; Budd & Nicholls, 1995). It is not clear, however, 
whether the reported interactions are specific for adenosine receptors, and whether 
they occur primarily at presynaptic or postsynaptic sites. Since these interactions 
may reduce the protective effect of adenosine, we have now extended the earlier 
work by studying paired-pulse interactions, comparing the effects of adenosine 
and the GABAb receptors agonist baclofen, identifying the nature of the 
adenosine and glutamate receptors involved, and examining the time course of the 
interactions.
Adenosine has two parallel modulatory roles in the CNS, acting as a homoeostatic 
modulator and also as a neuromodulator at the synaptic level. Adenosine is known 
as a substantial metabolite in neurons and other mammalian cell types, 
participating in the synthesis of nucleic acids, amino acid metabolism and 
modulation of cellular metabolic status (Stone, 1985). Considering the 
homeostatic role of adenosine related to the control of cellular metabolism, 
adenosine has been called a “local hormone” (Arch & Newsholme, 1978) and
“retaliatory metabolite” (Newby, 1984) to summarise the role of adenosine in 
stressful conditions. In some circumstances the intracellular concentration of 
adenosine increases from the nanomolar range to micromolar concentrations and 
adenosine is released to the extracellular medium to maintain the cell metabolism 
of neighbouring cells (Meghji, 1991).
Adenosine also acts as a neuromodulator in the nervous system. Adenosine 
modulates the release of neurotransmitters, the postsynaptic responses to 
transmitters, and the action of other receptor systems. Four adenosine receptors 
(Al, A2 a, A2b, As) belonging to the family of G protein-coupled receptors are 
known so far and have been cloned and pharmacologically characterized.
There are several experimental and pathological situations, such as hypoxia or 
ischaemia, in which there is increased release of glutamate from cells. In many of 
these same circumstances there is also an increase in the extracellular levels of 
adenosine (Stone & Simmonds, 1991; Latini & Pedata, 2001). Interactions 
between adenosine receptors and ionotropic excitatory amino acid transmission 
(via NMDA receptors) have previously been reported from our laboratory 
(Bartrup & Stone, 1988, 1990; Nikbakht & Stone, 2001), and there have been 
reports of interactions between adenosine and metabotropic glutamate receptors 
(de Mendonca & Ribeiro, 1997; Budd & Nicholls, 1995). It is not clear, however, 
whether the reported interactions are specific for adenosine receptors, and whether 
they occur primarily at presynaptic or postsynaptic sites. We have now, therefore, 
extended the earlier work by studying paired-pulse interactions, comparing the 
effects of adenosine and the GABAb receptor agonist baclofen, identifying the
1^1
nature of the adenosine and glutamate receptors involved, and examining the time 
course of the interactions.
Adenosine 
An historical prospective
The first report about the potent action of adenosine on the cardiovasculai* system 
was published more than 70 years ago (Drury & Szent-gyorgi, 1929). In the 1950s 
further evaluation on the effects of adenosine on mammalian cellular function was 
done (Green & Stoner, 1950; Winbury et al., 1953; Wolf & Berne, 1956). The 
hypotensive effects of adenosine were reconfirmed, as was the ability of the 
purine to modulate pulmonary and CNS function.
Sattin and Rail (1970) discovered the effects of adenosine on the accumulation of 
cyclic AMP (cAMP) in cortical slices together with the observations that 
adenosine is released from stimulated neuronal slices. In 1972 the modulatory 
function of adenosine on neuromuscular transmission was shown by Ginsborg and 
Hirst. In 1978, Bumstock suggested a division of receptors for adenosine and ATP 
into Pi and Pi-purinoceptor subtypes (Bumstock, 1978). This classification was 
based on four criteria: the relative potencies of ATP, ADP, AMP and adenosine, 
the selective actions of antagonists, the activation of adenylate cyclase by 
adenosine but not by ATP, and the induction of prostaglandin (PG) synthesis by 
ATP but not by adenosine. Thus this classification was proposed: PI 
purinoceptors are more responsive to adenosine and AMP than to ATP and ADP, 
methylxanthines such as theophylline and caffeine are selective antagonists for Pi 
receptors while P% purinoceptors are more responsive to nucleotides (such as ATP
and ADP) than to adenosine and AMP, and are not antagonised by 
methylxanthines.
Formation, release and inactivation of adenosine
Adenosine can either be synthesised intracellularly either de novo or retrieved by 
salvage and transported across the membrane, or can result from the metabolism 
of ATP. 5 -phosphoribosyl-1-amine (PRA) is the first product in the de novo 
pathway of adenosine formation. The amino acids glutamine, glycine and aspartic 
acid present nitrogen and carbon atoms for this pathway. In a subsequent reaction 
the parent purine nucleotide, inosine-5-monophosphate (IMP) is formed by 
utilising 5 molecules of ATP. Once IMP is formed it can be converted to the 
adenosine nucleotide derivative, AMP. Then cytosolic 5-nucleotidase acts on 
AMP and converts it to adenosine by dephosphorylation (Stone & Simmonds, 
1991; Meghji, 1991). Adenosine formation from the salvage pathway occurs with 
transmethylation of S -adeno s ylmethionine (SAM) that forms S- 
adenosylhomocysteine (SAH). SAH is metabolized further by SAH-hydrolase to 
adenosine and homocysteine (Ueland, 1982). Recycling of hypoxanthine to IMP 
by the enzyme hypoxanthine-guanine phosphoribosyl transferase (HGPRT) is 
another salvage route for adenosine production (Stone & Simmonds, 1991).
There is no evidence that adenosine is stored in synaptic vesicles and released 
from nerves similar to the other neurotransmitters (White & Hoehn; 1991). Much 
of the released adenosine arises from the intracellular adenosine that can pass 
bidirectionally via a facilitated-diffusional transporter. Adenosine accumulates 
during ischemia, hypoxia, head injury, and seizures (Hagberg et. al., 1987; Phillis,
1990; Bell et. al., 1998). Increased adenosine formation is due to the imbalance 
between energy supply and demand (Bardenheuer & Schrader, 1986). Potassium, 
veratridine and electrical stimulation have been shown to release adenosine both 
in vivo and invitro from various brain regions (White & Hoehn, 1991). 
Furthermore, excitatory amino acids can also induce adenosine release from brain 
slices (Latini & Pedata, 2001). It seems that the adenosine released during 
excitatory amino acid (EAA) activation will provide much protection against 
EAA mediated excitotoxicity in the CNS.
Some of the adenosine is produced from the extracellular metabolism of released 
adenine nucleotides, in particular ATP (Wieraszko et al., 1989; Cunha et, al., 
1996). ATP is co-stored with either noradrenaline in the sympathetic nerves or 
acetylcholine (Ach) in cholinergic synaptosomes (Morel & Meunier, 1981;White,
1988). This ATP could provide a source of adenosine by the action of 
ectonucleotidase.
Adenosine can be inactivated by uptake into neurons and neighbouring cells by a 
facilitated diffusion through the nucleoside transporters. This process is regulated 
by the concentration gradient for adenosine. After being taken up, it may be 
phosphorylated by adenosine kinase or deaminated by adenosine deaminase. In 
general, adenosine is phosphorylated at low adenosine concentrations and 
deaminated at high adenosine concentrations (Arch & Newsholme, 1978; Meghji, 
1991). Adenosine deaminase also exists in an extracellular form. Therefore, 
adenosine may be deaminated extracellularly without prior need to be taken up.
Adenosine receptors 
Classification
Adenosine receptors are members of the G protein-coupled receptor family and 
mediate the different physiological effects of adenosine. The broadest 
classification of adenosine receptors was proposed by Bumstock (1978). Based on 
this classification purine receptors were divided into Pi receptor subtypes 
preferring nucleosides such as adenosine and P2 receptor subtypes prefemng 
adenine nucleotides such as ATP and ADP. The Pi receptor was subdivided into 
Al and A2 subtypes according to whether they increased or decreased adenylate 
cyclase activity. Activation of Ai adenosine receptors inhibited adenylate cyclase 
and adenosine 3,5 "cyclic monophosphate (cyclic AMP) accumulation, while 
activation of A 2 adenosine receptors stimulated such activity (Van Calker, et. al., 
1979). Al receptors are preferentially activated by N^-substituted adenosine 
analogues such as L-N'^-phenylisopropyladenosine (L-PIA), whereas A2 receptors 
have preference for 5 - substituted compounds such as 5 -N-ethyl- 
carboxamidoadenosine (NECA) (Bumstock, 1989). In general Ai receptors are 
sensitive to low concentrations of adenosine derivatives in the nanomolar range, 
while micromolar concentrations are required for A2  receptor activation 
(Reddington & Lee, 1991).
A2  adenosine receptors have been subdivided into two subtypes, A2& with 
relatively high affinity for adenosine and A2b with lower affinity to adenosine.
In the early 1990s a new subtype of adenosine receptor, the A 3 receptor was 
cloned and characterized (Meyerhof, et al., 1991; Zhou, et al., 1992). 2-chloro-N^- 
(3-iodobenzyl)-5 -N-methylcaiboxamidoadenosine (L-IB-MECA) is the selective
agonist for A3 adenosine receptors with activation of this receptor mediating the 
inhibition of adenylate cyclase (Abbracchio et al., 1998).
Distribution
Information about the distribution of adenosine receptors has been revealed from 
the studies of biochemical and physiological roles of adenosine and radioligand 
binding studies. Radioligand binding studies have shown that Ai receptors 
predominantly existed in the molecular layer of the cerebellum and in the CAl 
and CA3 regions of hippocampus (Goodman & Snyder, 1982; Lee & Reddington, 
1986). Moderate A% receptor levels are found in the thalamus, caudate-putamen, 
septum, and cerebral cortex. Consistent with radioligand binding studies. Northern 
blot analysis of mRNA from various tissues has shown Ai adenosine receptor 
message in kidney, heart, testis and epididymal fat (Stehle et al., 1992).
Studies on A2 adenosine receptors have detected that both A^a and Aib receptors 
are expressed in brain. A2a receptor expression is limited to striatum, nucleus 
accumbens and olfactory tubercle whereas A2b receptor mRNA is distributed 
throughout the brain (Stehle et al., 1992).
The more sensitive RT-PCR technique (reverse transcription polymerase chain 
reaction) has shown that A2 a receptor mRNA can be detected in all brain regions 
(Dixon, et al., 1996). There are high level of A2a receptors in striatum and nucleus 
accumbens, and lower level in the cortex, amygdala, olfactory tubercles, 
hippocampus, hypothalamus, thalamus, and cerebellum. For example 
hippocampus contains approximately 25% of the striatal density of A2a receptors 
(Cunha, et al., 1994a).
%Northern blotting experiments have shown reasonable expression of the Aza 
receptors in heart, lung, thymus and epididymal fat, whereas A2b receptor message 
is demonstrated in the caecum, lung, intestine, urinary bladder, with lower 
distribution in lung (Stehle et al., 1992).
The expression of A2a receptors with other neurotransmitter binding sites has been 
found in some areas. For instance co-localization of A2a receptors and dopamine 
D2  receptors occur on striatopallidal neurons on the same cell and they can 
influence each other ® function (Johansson, et al., 1997).
Ligand binding Studies 
Agonist radioligands
[^H] Adenosine and [^H]2-choloroadenosine were the early radioligand 
compounds that were used to identify adenosine receptors by radioligand binding 
technology (Schütz & Burgger, 1982). Due to some difficulties such as 
degradation by tissue enzymes and unstability, these ligands have been replaced 
with the N^-substituted ligands, N^-cyciohexyladenosine (CHA) and R-N^- 
phenylisopropyl adenosine (R-PIA) (Williams, 1987). Both ligands have been 
widely used for several years as Ai-selective agonists. More selective N*^ - 
substituted agonists, including N^-cyclopentyladenosine (CPA) and 5 -chloro-N^- 
(2-endo-norbomyl) adenosine (CENBA) have been synthesized (Linden, 1991). 
CPA, CENBA and 2-chlorocyclopentyladenosine (CCPA) are the most potent and 
selective agonists for the Ai adenosine receptor (Miller & Hsu, 1992).
The A2 receptor has been further subdivided into A2a and A2b subclasses. Due to 
its high affinity for A2 a receptor, 5 -N-ethylcarboxamidoadenosine (NECA) has
been used as a radioligand for Aza receptors. However, NECA also binds with 
high affinity to Ai receptors, and to achieve selectivity for Aza receptors in NECA 
binding assays, it is necessary to block Ai receptors by addition of a highly 
selective Ai agonist such as CPA or the antagonist (Williams, 1987). 2-[P-(2- 
carboxyethyl)phenylethylamino]~5“N-ethylcarboxamidoadenosine (CCS 21680), 
a new ligand with high affinity and selectivity for Aza over Ai receptors has been 
developed. CGS 21680 and similar radioligands can directly label Aza receptor in 
rat brain without the need to block binding activity at the Ai receptor (Jarvis et al.,
1989). Useful radioligands for the Azb receptors have not yet been developed. 
Changes at two sites in adenosine structure at the N^- and 5 - positions are 
required to obtain high potency agonist for A3 adenosine receptors. N^-(3- 
iodobenzyl)-adenosine-5 -N-methyl-uronamide (IB-MECA) was the first highly 
potent and selective A3 receptor agonist both in vivo and in vitro (Von Lubitz, et 
al,, 1994; Stambaugh, et al., 1997; Jacobson, et al., 1997). It is 50-fold selective in 
binding assays for rat A3 vs Ai or Aza receptors.
Substituion of both N*"- and 5 positions in adenosine increased the A3 receptor 
affinity and selectivity. Therefore, 2-chloro-N^-(3-iodobenzyl)-adenosine- 5 -N- 
methyluronamide (2CI-IB-MECA) is 1400-fold selective for rat A3 vs either Ai 
and Aza receptors, respectively (Jacobson, 1998).
Antagonist radioligands
8 -phenylxanthines were developed as potent A 1-selective antagonists. Problems 
with some antagonists were their poor aqueous solubilities and variable activities 
as cyclic nucleotide phosphodiesterase inhibitors. Replacing the phenyl with
cyclopentyl on the 8 -position of xanthine results in compounds with improved 
affinity, aqueous solubility and selectivity for Ai receptors. l,3-Dipropyl-8- 
cyclopentyl xanthine (DPCPX) is a useful compound as a highly selective Ai 
antagonist (Liden, 1991). A keto derivative of DPCPX, KFM19 has been reported 
to have increased aqueous solubility (Ijzerman & Van Galen, 1990).
The most potent Az receptor antagonist 9-chloro-2-(2-furanyl)[l,2,4]triazolo[l,5- 
c]quinazolin-5-amine (CGS 15943) is a nonxanthine antagonist, originally 
synthesized as a benzodiazepine antagonist. CP- 6 6  713 is the only compound that 
combines high potency and greater than 1 0 -fold selectivity for Az receptors 
(Sarges et al., 1990).
Attempts to find selective xanthine-based antagonists for A3 receptors failed 
because xanthine tended to bind only weakly to A3 receptors. Different molecules 
were adopted in the design of selective A3 receptor antagonists. For example, 3- 
ethyl5-benzyl-2-methyl-6-phenyl-4-phenylethynyl-l,4-(±)-dihydropyiidine-3,5- 
dicarboxylate (MRS-1191) a trisubstituted l,4-dihydro-6-phenylpyridine 
analogue, has been found to inhibit radioligand binding at the human and rat A3 
receptors. In addition, MRS-1191 antagonised the effects of the A3 receptor- 
selective agonist IB-MECA on inhibition of adenylate cyclase (Jacobson et al., 
1997; Jacobson, 1998).
Naturally phenolic derivatives and other compounds such as 
triazolonaphthyridine, thiazolopyrimidine and a derivative of the 
triazoloquinazoline CGS 15943 have also been reported as high-affinity A3 
receptor selective antagonists (Jacobson et al., 1996; Kim et al., 1996).
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Peripheral actions of adenosine
Investigations on several organ systems have revealed that many physiological 
processes are modulated by extracellular adenosine acting at Ai receptors. These 
include the inhibition of lipolysis and stimulation of glucose uptake in adipocytes 
and modulation of neurotransmitter release in the central nervous system (Olsson
A.
& Pearson, 1990).
%The cardiovascular effects of adenosine have been intensively studied, including 
negative inotropy and chronotropy that are mediated by the Ai receptor subtypes.
Aza receptor activation in vascular beds initiates smooth muscle relaxation, 
resulting in vasodilation and drop in blood pressure (Olsson & Pearson, 1990).
Activation of Aza receptors on platelet membranes elevates intracellular cAMP 
levels, resulting in the inhibition of platelet aggregation (Palmer & Stiles, 1995).
Adenosine is able to inhibit neutrophil activation, subsequently decreasing 
neutrophil adhesion to endothelial cells and preventing capillary plugging (Miller 
& Hsu, 1992).
Exogenous adenosine affects all aspects of renal function such as renal blood 
flow, glomerular filtration rate, renin secretion and transmitter release from renal 
efferent nerves. Since many of these effects are antagonized by alkylxanthines and 
mimicked by adenosine analogs acting as adenosine receptor agonists, they are 
produced by adenosine receptors (Churchill & Bindani, 1990). The capability of 
adenosine to induce bronchoconstriction has been demonstrated in the respiratory 
system (Churchill & Bindani, 1990).
I;■I
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Central actions of adenosine
IAdenosine is a modulator that has generally inhibitory effects on neuronal 
activity. Activation of adenosine receptor by adenosine in brain tissue leads to 
inhibitory effects that seem to be mediated by both adenosine Ai and Aza 
receptors. The involvement of adenosine in diverse neural phenomena, include 
regulation of sleep, neuroprotection, regulation of seizure susceptibility, 
locomotor effects, analgesia, mediation of the effects of ethanol and chronic drug 
use has been demonstrated (Schwarz-Bloom et al., 1999; Fiorillo & Williams,
2000; Mendelson, 2000; Dunwiddie & Masino, 2001).
Different adenosine receptors may be involved in the neuroprotective function. At 
least three cellular mechanisms are mediated via Ai receptors, including inhibition 
of transmitter release (in particular glutamate), hyperpolarization of neurons, and 
directly inhibition of certain kinds of Ca^ '*' channels. These mechanisms could 
reduce excitotoxicity by decreasing Ca^ "^  entry, which is thought to be a key step 
in excitotoxic damage. Also by reducing metabolic rate, adenosine helps to 
preserve ATP stores that are essential for pumping the Ca^ "*" out of the cell 
(Dunwiddie & Masino, 2001).
Presynaptic effects of adenosine
Under most experimental conditions, the effect of adenosine or adenosine receptor 
agonists is an inhibition of neuronal activity mediated by Ai receptor activation.
Ai receptors are linked to inhibition of the release of the most classical 
neurotransmitters, including glutamate, gamma-amino butyric acid (GABA), 
norepinephrine, acetylcholine, 5-hydroxytryptamine (5-HT), and dopamine
".,1
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(Dunwiddie, 1985; Greene & Hass, 1991). Inhibitory effects are generally seen on 
excitatory glutamergic systems. Inhibitory modulation of inhibitory systems (e.g.
GABA) is less frequently observed, therefore the net effect of adenosine receptor 
activation in almost all regions of the brain is to reduce excitability. It was 
recognised that the inhibitory action of adenosine in the CNS predominantly 
results from its presynaptic action (Lupica, et al., 1992). This inhibitory 
modulation of transmitter release depends on a direct inhibition, via G-proteins, of 
mainly N-type calcium channels, although this is still the subject of debate (Wu &
Saggau, 1994a; Ribeiro, 1995). Further inhibitory mechanisms of adenosine effect 
seem to operate in motor neurons. Silinsky et al. (1989) have shown that 
intracellular calcium buffers do not prevent the inhibitory effects of adenosine on
5 :acetylcholine release (Silinsky, 1989). This and other studies suggest that 
adenosine inhibits transmitter release from motor nerves by reducing the 
responsiveness of some component of the secretory apparatus to Ca^ "*". Adenosine 
by inhibiting phospholipase, could inhibit neurotransmitter release by reducing 
intraneuronal Ca^^ mobilization and by attenuating the activation of PKC.
It is also possible that adenosine modulates potassium currents in presynaptic 
teiTninals. In support of this possibility, it has been demonstrated that blockers of 
potassium channels (e.g. 4-aminopyridine) are able to prevent the inhibitory 
effects of adenosine on transmitter release in peripheral sympathetic nerves 
(Stone, 1981a) and in glutamate-releasing fibers in the hippocampus (Scholfield 
& Steel, 1988).
Adenosine receptors may also enhance neurotransmitter release, but these actions 
are less common than the inhibition of transmitter release (Cunha et al., 1994b).
The development of Aza receptor agonists and antagonists has provided tools to 
find the role of Aza receptors in the control of neurotransmitter release in different 
brain regions as well as in the peripheral nervous system. In striatal cholinergic 
nerve terminals, at the neuromuscular junction and in hippocampus, GABAergic 
nerve terminals, modification of neurotransmitter release via Aza receptors is 
decreased by inhibitors of adenylate cyclase (Cunha & Ribeiro, 2000a; Gubitz et 
al., 1996). Protein kinase C (PKC) or phospholipase inhibitors are able to inhibit 
the effects of Aza receptors, whereas protein kinase A (PKA) inhibitors slightly 
inhibit or do not change the effects of Aza receptor activation. Further 
investigation has demonstrated that activation of Aza receptors triggers cAMP 
accumulation but a parallel signaling system via PKC is also activated by 
presynaptic A2a receptor activation (Cunha & Ribeiro, 2000b).
Aza receptors can also modify neurotransmitter release via P-type calcium 
channels where its activity seems to be modified by both PKC and PKA. 
However, it is not clear whether both pathways can modulate this same target or 
just P-type calcium channels are the main target for PKC pathway (Cunha, 2001).
Postsynaptic effects of adenosine
Postsynaptic mechanisms comprise activation of K^ channels and the control of 
Ca^ "^  fluxes (Fredholm & Dunwiddie, 1988; Allgaier et al., 1991). Postsynaptic 
inhibition is mediated via activation of Ai adenosine receptors and an increase in 
K^ conductance which seems to be mediated via ATP- sensitive K^ (KATP) 
channels (Li & Henry, 1992).
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Pertussis toxin (PTX) is known to ADP-ribosylate and inactivate several types of 
G-proteins. Postsynaptic effects of adenosine could be blocked by PTX treatment 
in vivo (which caused adenylate cyclase inhibition, increased K'*' conductance) 
while presynaptic effects have not been affected by PTX (Gilman, 1987).
Post-receptor mechanisms
A cascade of intracellular events occurs after stimulation of adenosine receptors 
that transduce extracellular signals to effector responses such as ion channels, 
adenylate cyclase and phospholipase C via G-proteins.
G-proteins
Intermediatory guanine nucleotide-binding proteins (G proteins) can modulate ion 
channels directly via physical interactions between G-protein subunits and the 
channel protein, or indirectly via second messengers and protein kinases. G 
proteins are not a single protein but consist of a heterotrimeric protein with alpha, 
beta and gamma subunits (Dascal, 2001). The a-subunit directly regulates 
adenylyl cyclase and other enzymes and effectors. The p/y subunit complex is 
required for efficient coupling of the a-subunit to receptors, and influences the 
rate of GDP dissociation from the GTP/ GDP binding site. The number of 
heterotrimeric G protein subunits identified in the sequence of human genome 
study consists of 7 alph, 5 beta and 14 Gamma subunits (Albert & Robillard, 
2002).
Many neurotransmitter receptors act via G-proteins including adenosine receptors. 
Ai receptor-mediated responses are coupled via pertussis toxin sensitive G-protein
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to different effectors including adenylate cyclase, phospholipase C, Ca^^ channels,
C r channels and channels (Dascal, 2001).
Adenylate cyclase and the cyclic AMP system
Adenylyl cyclase (AC) converts ATP to cyclic AMP. This enzyme is regulated by 
hormones, neurotransmitters and other regulatory molecules through its 
interaction with G-proteins and receptors. A total of nine isoforms of adenylyl 
cyclase have been cloned in mammals and they are numbered from AC1-AC9 I
(Hanoune, et al., 1997).
Adenosine Ai and Az receptors were initially characterized on the basis of their 
effect on adenylyl cyclase and production of cAMP. Adenosine Az receptor 
agonists increase the rate of ATP metabolism to cAMP by enhancing the activity 
of adenylyl cyclase through its action with stimulatory G protein. Conversely, 
adenosine Ai receptor agonists inhibit the rate of ATP metabolism to cAMP by 
attenuating the activity of adenylyl cyclase, through its action with the inhibitory 
G protein.
Ai and Az adenosine antagonists including caffeine and other methylxanthines, 
block both the stimulatory and inhibitory actions of adenosine on adenylyl cyclase 
(Sattin & Rail, 1970; Hanoune, et al., 1997).
Diacylglycerol/ phosphatidyl inositol
Inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) are generated from 
the breakdown of the phospholipid, phosphatidylinositol-4,5-bisphosphate (PIP2) 
due to action of the enzyme phospholipase C. These compounds act as second 
messengers mediating the effects of many neurotransmitters including 
acetylcholine, 5-hydroxy try ptamine and noradrenaline and form the
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internalization of the extracellular signal. Adenosine does not seem to have any 
direct effect on phosphati dylino sitol turnover. However, adenosine and several 
analogues have been reported to mediate the regulation of phosphatidylinositol 
(PI) responses to other neurotransmitters such as histamine and noradrenaline 
(Morgan, 1991).
Glutamate receptors
Glutamate receptors (GluRs) mediate most of the excitatory neurotransmission in 
the mammalian central nervous system (CNS). They also participate in most 
aspects of normal brain function including cognition, memory, and learning 
(Headley & Grillner, 1990). Glutamate and related excitatory amino acids are 
toxic to central neurons. Excessive activation of GluRs during stress to the brain, 
such as ischemia, head trauma and epileptic seizure lead to the death of central 
neurons. The glutamate neurotoxicity may also be involved in the producing of 
various neurodegenerative disease (Choi & Rothman, 1990). Therefore, GluRs 
participate in both the physiology and pathology of brain functions.
The GluRs have been classified into two major classes, ionotropic and 
metabotropic receptors. The ionotropic receptors (iGluRs) contain cation-specific 
ion channels, and include three subclasses of receptor: a-amino-3-hydroxy-5- 
methyl-4-isoxazole propionate (AMPA), kainate (KA) and N-methyl-D-aspartate 
(NMDA) receptor channels. The metabotropic glutamate receptors (mGluRs) are 
coupled to GTP-binding proteins (G-proteins) and modulate the production of 
intracellular messengers (Ozawa, et al., 1998).
Ionotropic glutamate receptors 
AMPA receptors
Glutamate activates three major types of ionotropic receptor namely, AMPA, KA, 
and NMDA receptors. Since neither agonists nor antagonists could distinguish 
between AMPA and KA receptors, they were often, collectively referred to as non 
NMDA receptors. These AMPA receptors were initially called quisqualate 
receptors. Since quisqualate could also act on mGLUR and AMPA affected 
ionotropic receptors, they were more specifically renamed AMPA receptors. 
Mammals express four AMPA receptor subunits GLUR1-GLUR4, that are 
distributed throughout the CNS (Danysz et al, 1995).
The AMPA receptor has at least three separate binding sites at which agonists or 
antagonists can act: glutamate binding, desensitization and intra-ion channel 
binding sites. AMPA receptor channels are permeable only to Na"^  and K^ and 
almost impermeable to Ca^^ in central neurons. However, it was found that 
AMPA receptors displayed a substantial permeability to Ca^^ and a strong inward 
rectification in cultured rat hippocampal neurons. In contrast, AMPA receptor 
displayed a slight outward rectification and low peimeability to Ca^ "^  in certain 
neurons like xenopus oocytes (Ozawa et al., 1998).
Kainate receptors
Kainate is a potent agonist of the AMPA receptor, but it also activates a distinct 
class of iGluRs, i.e. Kainate-preferring receptors (KA). A family of KA receptors 
has been cloned and five subunits, termed GluR5, GluR6 , GluR7, K A l, and KA2 
have been identified. KA receptors on the presynaptic terminals at hippocampal 
CAl synapses negatively regulate the synaptic release of glutamate, but KA
'"'mm,
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enhances transmitter release from synaptosomes prepared from the hippocampal 
CA3 region. Therefore, modulating actions of presynaptic KA receptors may vary 
from synapse to synapse (Ozawa, et al., 1998).
NMDA receptors
These receptors are coupled to high conductance cationic channels permeable to 
K^, Na'  ^ and Ca^ "^  and are modulated positively by polyamines (spermine and 
spermidine) and glycine, which binds to a specific, strychnine-insensitive site. 
The NMDA channels are blocked in a use and voltage dependent manner by 
Mg^ "^ . This means that NMDA receptors are only activated following 
depolarisation of the postsynaptic membrane by, for example, AMPA receptor 
activation, which relieves their voltage -  dependent blockade by Mg^ "^ . This 
biophysical property and the high Ca^^ permeability of NMDA receptors make 
them inherently suitable for their role in mediating synaptic plasticity such as that 
underlying learning processes. Similar to Mg^^, uncompetitive NMDA receptor 
antagonists such as ketamine, dextromethorphan, memantine, phencyclidine and 
MK-801 block the NMDA channel in the open site (Collingridge & Watkins, 
1994).
NMDA receptors also exist in multiple forms, probably as pentameric assemblies, 
which have different physiological and pharmacological properties and are 
distributed throughout the brain. So far two major subunits NMDARl and 
NMDAR2, have been cloned from the rat CNS. Alternative splicing has revealed 
eight functional isoforms for the NMDARl subfamily (NMDARl A-
NMDARl H). The NMDAR2 subfamily consists of four individual subunits, 
NMDAR2A-NMDAR2D (Collingridge & Watkins, 1994).
Investigations have shown that the NMDA response is potentiated by glycine in 
cell cultures of central neurons. Later, it was revealed that glycine is not only a 
strong potentiator of the NMDA receptor but is also required to open the NMDA 
receptor channel, so that glycine has a co-agonist role for this receptor. It has been 
proven that the NMDA receptor response in culture and in brain slice preparations 
are due to existing endogenous glycine (Vyklicky et al., 1990).
The NMDA receptor is characterized with three properties: (a) It remains blocked 
at resting potentials by Mg^ "^ . After depolarisation ionic currents occur through the 
receptor, (b) Considerable amounts of extracellular Ca^^ enter the intracellular 
space during the opening of the receptor (c) NMDA receptor-mediated 
neurotransmission occurs slowly and lasts for a long period. These properties 
make the NMDA receptor a molecular appaiatus that can identify the coincidence 
of the presynaptic depolarization and induce in the postsynaptic cell an adequate 
amount of the second messenger ion Ca^ "^  that will initiate synaptic plasticity 
(Kaczmai'ek et al., 1997). There is much evidence to suggest that AMPA and 
NMDA receptors are colocalized and activated by the transmitter glutamate, 
released into the synaptic cleft. Therefore, it seems that the AMPA receptor has a 
low affinity and becomes unbound quickly after the clearance of the transmitter, 
while the NMDA receptor has a greater affinity, causing a long binding (Ozawa et 
al., 1998).
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Metabotropic glutamate receptors
The mGluRs represent a large family of G protein-coupled excitatory amino acid 
(EAA) receptors that activate multiple second messenger systems leading to 
various signal transduction processes and are distinct from the iGluRs that form 
ion channels. The mGluRs can be classified into three groups based on their 
sequence homology, transduction mechanism and pharmacology (Nakanishi, 
1994; Conn & pin, 1997). Group I mGluR receptors (mGluRi and mGluRg) 
stimulate phospholipase C, resulting in an increase in phosphoinositide turnover 
and the subsequent activation of protein kinase C and Ca^ '*’ release from internal 
stores. Group II (mGluRz and mGluRs) and III (mGluR4,6 .7 ,8  ) receptors inhibit 
adenylyl cyclase, leading to the reduction of cAMP formation in the cell (Baskys, 
1992; Conn & Pin 1997).
The mGluRs play an important role in the regulation of synaptic transmission via 
their modulation of ion channels and ionotropic glutamate receptors in diverse 
neuronal cell types (Pin & Duvoisin, 1995; Conn & Pin, 1997). For example 
activation of mGluRs induces an inward current that is possibly mediated via 
sodium channels in rat dopamine mesencephalic neurons and decreases currents 
through voltage-dependent calcium channels in rat hippocampal (Swartz & Bean,
1992) and striatal neurons (Stefanie et al., 1994). Different subtypes of potassium 
channels may also be modulated by mGluRs in several types of neuronal cells 
(Conn & Pin, 1997). Activation of mGluRs has been shown to potentiate AMPA- 
mediated responses in neurons of the tractus solitarius nucleus (Glaum & Miller,
1993) and NMDA-mediated currents in hippocampal neurons (Aniksztejn et al., 
1992; Behnisch & Reymann, 1993; Fitzjohn et al., 1996) but to attenuate NMDA-
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mediated responses in neostriatal neurons (Colwell & Levine, 1999). These results £
indicate that the activation of mGluRs has diverse effects on the modulation of 
iGluR as well as of ion channels in different cell populations, and thus may play a 
unique role in regulating synaptic transmission in different brain regions (Conn &
Pin 1997; Glaum & Miller, 1993; Colwell & Levine, 1999).
The mGluRs also have a role in various forms of synaptic plasticity. It has been 
reported that the induction of long-term potentiation (LTP) in the hippocampus 
requires synaptic activation of mGluRs (Bashir et al., 1993; Riedel et al., 1995), 
and hippocampal LTP is greatly reduced in mGluRl knock-out mice (Aiba et al.,
1994). MGluRs are also involved in the induction of long-term depression (LTD) 
at parallel fiber-Purkinje cell synapses in the cerebellum (Linden & Connor, 1993;
Hartell, 1994). Activation of group I mGluRs with the selective agonist (RS)-3,5- 
dihydroxyphenylglycine (DHPG) induces LTD in the CAl region of hippocampal 
slices in Mg^ "^  free medium or during blockade of GABA-mediated inhibition 
(Palmer et al., 1997).
Group I metabotropic glutamate receptors
Group I includes mGluRi and mGluRg which are positively coupled to PLC and 
lead to an increase in diacylglycerol (DAG) and inositol trisphosphate (IP3) and in 
some cases to an activation of adenyl cyclase (Conn, et al., 1997).
Over recent years the group I mGluRs have been extensively studied in 
experimental animals, leading to an appreciation of their great importance in the 
CNS. Structures including the hippocampus, cortex, thalamus and cerebellum and 
involvement of these receptors in a variety of disorders including epilepsy.
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ischemia, pain and neurodegenerative diseases is beginning to emerge. Cloned 
mGluRs expressed in heterologous mammalian systems have been used to 
characterize the activity of selective compounds on mGluR subtypes. Quisqualate 
is the most potent agonist of these receptors followed by ibotenate and glutamate. 
The group I mGluR specific agonists are 3,5-dihydroxyphenylglycine (DHPG), 3- 
hydroxyphenylglycine (3-HPG) and trans-azetidine-2,4-dicarboxylate (t-ADA), 
which are devoid of activity in other mGluR groups, A new phenylglycine 
derivative, (RS)-Z-chloro-5-hydroxyphenylglycine (CHPG), has been recently 
reported to activate only mGluRg. but not mGluRi in transfected cells. This is the 
first compound available to distinguish pharmacologically the two members of the 
group I, although it is not very potent (Bordi & Ugolini, 1999).
Distribution of group I mGluRs in the mammalian brain
Studies of the distribution of the mRNA for mGluRi by in situ hybridization 
revealed an abundant expression of this receptor in hippocampal neurons and 
cerebellar Purkinje cells. In the cerebellum, mGluRi is distributed in cells and 
dendrites of Purkinje, stellate and some Golgi cells. No mGluRg is found in the 
cerebellum, except a small amount in the granule cell layer but not in the Purkinje 
cells. Other areas of expression of mGluRi are the olfactory bulb, the amygdala, 
the thalamus and the basal ganglia. The presence of this receptor in these area has 
inspired study of the potential role of group I mGluRs in extrapyramidal motor 
diseases like Huntington's chorea or Parkinson’s disease (Bordi & Ugolini, 1999; 
Rouse et al., 2000).
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In the hippocampus, mGluRi are concentrated in the postsynaptic membrane at 
the periphery of synaptic junctions, but ionotropic glutamate receptors are 
concentrated within the synaptic junction. Because of the special segregation of 
ionotropic receptors and mGluRs, it has been suggested that they may respond 
differently to glutamate stimulation; the ionotropic receptors respond to glutamate 
under normal presynaptic stimulation, whereas the perisynaptic mGluRi is 
involved in excitatory responses evoked only by strong presynaptic stimulation. 
The postsynaptic metabotropic receptors situated at the periphery would appear to 
have a role of delayed activation (Conn, et al., 1997).
The hippocampus of the rat and the human contains many neurons that express 
mGluRg. In the CAi region of the rat mGluRg is present in both pre and 
postsynaptic membranes. Most CAg pyramidal and granule cells express both 
mGluRs and mGluRi (Ozawa, et al., 1998). Immunocytochemistry studies have 
shown while mGluRs is the most abundant group I mGluR in CAi pyramidal cell, 
these cells express mGluRi mRNA as well (Beithele et al., 1998; Ferraguti et al, 
1998). Therefore, it is possible that both mGluRi and mGluRg are involved in 
regulating CAi pyramidal cell function.
Neurophysiological role of group I mGIuRs
Substances that activate group I mGluRs cause neuronal depolarization and 
excitation while antagonists of these receptors inhibit depolarization and 
excitation. In addition, activation of these receptors can modulate synaptic 
transmission by regulating GABA release or by interfering with iGluRs. Recent
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evidence has also shown the importance of group I mGluRs in modulating other 
brain neurotransmitter systems.
Neuronal excitability
Application of the broad spectrum mGluR agonist ACPD produces various 
physiological effects, both inhibitory and excitatory. Group I mGluRs seem to 
involve primarily postsynaptic excitatory effects. In the CAi area of the 
hippocampus, activation of mGluRs with ACPD leads to depolarization, increase 
of input resistance, and reduction in spike frequency adaptation (Desai et al., 
1992; Mannaioni et al., 1999). The increase in neuronal excitability caused by 
activation of group I mGluRs is produced primarily by modulation of potassium 
channels. ACPD induces net inward currents by inhibiting K'*' conductances in 
neurons in hippocampus, amygdala, and hypothalamus. This effect is blocked by 
group I mGluR selective antagonists (Gereau & Conn, 1995). In the CA3 region of 
the hippocampus the reduction of conductance in response to mGluR 
activation is not mediated by PKC or PKA and it exhibits a voltage sensitivity 
which could be important in physiological processes such as long lasting changes 
in cellular excitability or persistent modification of synaptic efficacy (Bordi & 
Ugolini, 1999).
Activation of group I mGluRs can also modulate cuiTents through N-type, L-type 
and other voltage dependent calcium channels. Quisqualate inhibits N-type Ca 
channels in hippocampus and cortex, where it is mediated by G-protein and does 
not involve protein kinases, but it facilitates L-type channel function in the
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granule cells of the cerebellum via G-protein mechanism not sensitive to pertussis 
toxin (Bordi & Ugolini, 1999).
Modulation of synaptic transmission
Activation of presynaptic mGluRs causes a widespread reduction of glutamatergic 
transmission in the CNS. This action is determined almost exclusively by 
presynaptic group II and group III mGluRs. Reduction of glutamatergic 
transmission attributed to group I mGluRs has been observed in the hippocampus, 
at the level of the synapses between Schaffer collaterals and CAi pyramidal cells 
(Gereau & Conn, 1995; Conn & Finn, 1997). In this region inhibition of fEPSPs is 
induced by DHPG or quisqualate and is accompanied by an increase in paired- 
pulse facilitation, a common and reliable test of presynaptic mechanisms. MGluRs 
probably mediates this effect because there is immunochemical evidence for the 
presynaptic expression of mGluRs in CAi neurons (Gereau & Conn, 1995; 
Romano et al., 1995).
Modulation of neurotransmitters
It is now becoming evident that mGluRs regulate different neurotransmitters in a 
number of brain structures. Activation of mGluRs reduces GABAergic synaptic 
transmission in the hippocampus, the striatum, the thalamus, and the olfactory 
bulb. The identity of the mGluR group responsible for this effect is not certain, 
but evidence for a presynaptic activation of group II or III receptors is emerging.
In the hippocampus, GABAergic intemeurons can be activated by mGluR either 
pre or postsynaptically. In the CA3 region activation of group I mGluRs,
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presumably located on the somato-dendritic membrane of GABA intemeurons, 
enhances excitability. In contrast, group II mGluRs are located on the inhibitory
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terminals and reduce GABA release. In the CAi region, group I mGluRs are 
involved in modulating transmission from GABAergic intemeurons onto 
pyramidal cells. Analysis of spontaneous inhibitory postsynaptic currents (IPSCs)
suggests that these receptors are located presynaptically (Vezina & Kim, 1999).
In the hippocampus DHPG (specific group I mGluR agonist) is able to attenuate 
the inhibitory effects of adenosine Ai receptor activation and this attenuation 
occurs via a PKC-dependent mechanism. This interaction may be relevant to the 
pathology that occurs after hypoxia, where adenosine is an endogenous protective 
substance (Ozawa, et al., 1998).
In cultures of astrocytes, mGluRg is associated with the regulation of p-adrenergic 
receptor function. The agonist DHPG, but not agonists for group II or III mGluRs, 
potentiates cAMP accumulation induced by p-adrenergic stimulation. This effect 
is independent of intracellular Ca '^  ^or the PKC pathway, but can contribute to the 
opening of Ca^ "^  channels and modulate neuronal activity by a feedback process to 
neurons (Balazs, et al., 1997).
Activation of mGluRs has been shown to modulate NMDA and AMPA receptor- 
mediated membrane currents in a number of brain areas and cell types (Colwell &
Levine, 1999; Fitzjohn et al., 1996; Colwell & Levine, 1999). Potentiation of 
NMDA responses by ACPD was reported in the CAi region of the hippocampus, 
cerebellum, neocortex, striatum and spinal cord. In some studies, however, ACPD
■ai
attenuates NMDA responses and this discrepancy can be explained by the NMDA 
receptor composition in different cell types (Shen et al., 1995).
ACPD also potentiates AMPA receptors in spinal cord and visual cortex but not in 
the hippocampus. The potentiation of excitatory responses is explained by an 
mGluR-mediated depolarization that increases cell excitability. Inhibition of 
currents is implicated in these mGluR-induced depolarizations, resulting in an 
increase in cell input resistance. PKC, which is triggered by activation of group I 
mGluRs, has been proposed to mediate the potentiation of iGluR responses (Bordi 
& Ugolini, 1999).
Group II metabotropic glutamate receptors
Group II mGluRs consist of mGluRz and mGluRs and are negatively coupled 
with the adenylyl cyclase system. Group II mGluRs are potently activated by ( 
25,PR, 2'R,3'R)-2-(2,3-dicarboxy cyclopropyl) glycine (DCG-IV) (Pin & 
Duvoisin, 1995).
Most of the physiological roles and pathological implications of group II receptor 
subtypes have been associated with their presynaptic localization. Indeed, group II 
mGluRs inhibit transmitter release from cortico-striatal terminals, a pathway that 
affects the functions of a large percentage of caudatal neurons (Ozawa, et 
al.,1998).
Group II agonists are also thought to exert a role in protection against glutamate 
excitotoxic neuronal cell death. A possible mechanism for group II agonist- 
mediated neuroprotection involves the release of trophic factors such as 
transforming growth factor p (TFG-P), a known endogenous neuroprotective 
agent upon stimulation of mGluR3 subtypes localized in astrocytes (Pellicciari & 
Costantino, 1999).
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Group III metabotropic glutamate receptors
Group III mGluRs consist of mGluR^,6 ,7 ,8 that are negatively coupled with the 
adenylyl cyclase system. The major agonist of this group is a phosphonate 
analogue of glutamate, L-2-amino-4-phosphonobutyric acid (L-AP4) (Pin & 
Duvoisin, 1995). Group II and III mGluRs are coupled to the inhibition of 
adenylyl cyclase. Group II show strong inhibition of forskolin-induced cAMP 
formation. All these effects of group II and III are strongly inhibited by PTX, 
suggesting that the G-proteins involved in the coupling are of the Gi family.
Group III mGluRs paiticipate in the modulation of glutamate release and the 
prevention of excitotoxicity in different cell types (Gereau & Conn, 1995). A 
potential neuroprotective role of group III receptors has been postulated in cortical 
cultures, although the involvement of specific subtypes still need clarification. 
Recently mice lacking mGluR4  showed altered spatial learning and memory, 
indicating a role for the presynaptically expressed mGluR4  in the process of 
learning (Romano, et al., 1995).
Metabolism of glutamate
Overactivation of glutamate receptors is harmful and glutamate is toxic in high 
concentrations. To reduce damage Glutamate is removed from the extracellular 
space, to reduce its action on glutamate receptors which exist on most of the 
cellular elements (dendrites, nerve terminals, neuronal cell bodies & glial cells). 
There is no evidence for any extracellular enzyme that can metabolise glutamate. 
The rapid route to remove glutamate from extracellular space is cellular uptake. 
Simple diffusion is also a substantial way for glutamate removal from synaptic
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cleft. After being taken up into astrocytes, glutamate may be metabolised via two 
different pathways: (a) it may be converted to glutamine in an ATP-dependent 
route and released to the extracellular fluid. Glutamine is taken up via glutamine 
transporters by neurons which is reconverted to glutamate and is reused as 
transmitter (the glutamate-glutamine cycle)(Fonnum 1993;, Laake et al., 1995; 
Danbolt, 2001). (b) It may be metabolised to a-ketoglutarate by deamination or 
transamination, a-ketoglutarate may be converted to succinate, fumarate and 
mal ate in the tricarboxylic acid cycle. Malate may be further metabolised in the 
tricarboxylic acid cycle, or it may be decarboxylated to pyruvate and lactate which 
has been shown in vitro (Mckenna et al., 1996; Danbolt, 2001). Lactate is 
transported from astrocytes to extracellular fluid that can enter neurons.
GABA receptors
y-aminobutyric acid is the most widely distributed inhibitory neurotransmitter in 
the central nervous system and is released via many cells, particularly by 
intemeurons. GABA receptors are divided into two classes: ionotropic receptors 
(e.g. GAB A A , GAB Ac) and metabotropic receptors (e.g. GABAb). The GABAa 
receptors directly act on a chloride ionophore and are composed of modulatory 
binding sites for benzodiazepines, barbiturates and neurosteroids. Structurally 
GAB Ac receptors seem to be very similar to GABAa receptors. The GABAa 
responses are blocked competitively by bicuculline and non -competitivel y by 
picrotoxinin. GAB Ac receptors are activated selectively by cis-4-aminocrotonic 
acid (CACA) and are blocked competitively by [( 1,2,5,6-tetrahydropyridine-4-yl) 
methylphosphonic acid] (TPMPA) and non-competitively by picrotoxinin.
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GAB Ac receptors do not respond to bicuculline, GABAa modulatory drugs and ?
baclofen (Chebib & Johnston, 1999; Bormann, 2000).
'I
GAB As receptors are coupled to Ca^ "^  and channels via G- proteins. These 
receptors are activated by P-chlorophenyl GABA (baclofen) and are resistant to 
drugs that modulate GABAa receptors (Bowery et al., 2 0 0 0 ). GABAb receptors
Iare present at both postsynaptic and presynaptic sites. Activation of GABAb
+ ■'''receptors in the CA3 area of the hippocampus activates postsynaptic K |
éconductances via pertussis toxin-sensitive G-proteins (Thompson & Gahwiler,
1992). In addition to their postsynaptic actions GABAb receptors are involved in 
the presynaptic inhibition of neurotransmitter release. In the hippocampus,
GABAb receptors mediate inhibition of both GABAergic and glutamatergic 
transmission. It seems that both N-type and non N-type calcium channels 
contribute to the action of GABAb receptors on inhibitory transmission (Doze et 
al., 1995; Bonanno et al., 1997).
Nitric oxide
Activation of NMDA receptors suppresses neuronal responses to adenosine in 
hippocampal slices. Since NMDA receptor activation leads to the generation of 
nitric oxide (NO) and superoxide, we have considered whether these can modify 
neuronal responses to adenosine and mediate the actions of NMDA. Nitric oxide 
(NO) is formed from the amino acid ai'ginine by the enzyme nitric oxide synthase 
(NOS). Since NO is a labile free radical, it is not synthesized in advance and 
stored in synaptic vesicles as are other known neurotransmitters. Therefore, it 
must be synthesized on demand and acts immediately. Its effects are brief because
NO is a highly reactive free radical that remains for less than 10 seconds before it 
reacts with oxygen and water to form inactive nitrates and nitrites (Zhang and 
Snyder, 1995). NO plays a role in long term potentiation. In the CAl region of the 
hippocampus the induction of most forms of LTP by high frequency stimulation is 
dependent on Ca^ "^  entry into the post synaptic neuron by NMDA receptor 
activation (Pellmar & lipinski, 1992) and partly causes an increased in presynaptic 
release (Malinow, 1991; Bolshalcov & Siegelbaum, 1995). NO may act as a 
retrograde messenger in LTP. It activates soluble guanylyl cyclase (SGC) that 
generates the intracellular second messenger cyclic GMP (cGMP). Interestingly, 
tetanic stimulation of hippocampal slices results in large rises in cGMP that are 
blocked by NOS inhibitors (Chetkovich et al., 1993; Lu et al., 1999). Cytosolic 
cGMP acts on the activity of various receptor proteins, including the cGMP- 
dependent protein kinase (cGK). There is some evidence that indicate cGK plays a 
role in the induction of LTP such as: cGK inhibitors block LTP, and cGK 
activators can facilitate LTP in response to rather weak tetanic stimulation (Zhuo 
et al, 1994; Arancio et al., 1995). However, studies on mice lacking the genes for 
cGKl, cGK2 or both have not shown any changes in LTP although LTP could be 
reduced by using NOS inhibitors and NMDA antagonists, respectively (Kleppisch 
et al., 1999).
Protein kinase C (PKC) is also one of the necessaiy biochemical steps for the 
induction of LTP (Malinow et ah, 1989). An additional mechanism that might 
participate in the activation of PKC during the induction of LTP is an oxidative 
mechanism consisting of reactive oxygen species (ROS) such as superoxide anion 
( 0 2  °). The level of superoxide increases during the induction of LTP (Bindokase
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et a l, 1996; Klann et a l, 1998; Knapp & Klann, 2002). It has been observed that 
NMDA receptor activation in the CAl region of hippocampal slices causes 
increased production of superoxide and with increasing superoxide levels, it has 
been shown to increase PKC activity (Palumbo et al., 1992). Furthermore, recent 
studies show that superoxide dismutase (SOD), which removes the superoxide, 
impaired LTP (Gahtan et ah, 1998; Thiels et ah, 2000). Another interesting target 
for NO in LTP may be a cytosolic ADP-ribosyltransferase (ADPPT) (Brune and 
Lapetina, 1989). An NO-stimulated ADPRT may ribosylate a GTP binding 
protein or other enzyme, which alters ion channel activity or changes the Ca^ '*’ 
sensitivity of the neurotransmitter release process such that more neurotransmitter 
is released during LTP (Schuman & Madison, 1994). Certain studies have shown 
that LTP can be prevented by extracellular application of ADP-ribosyltransferase 
inhibitors (Schuman et ah, 1992). ADP-ribosylation is occluded partly in 
hippocampal slices by LTP induced by tetanic stimulation but is not reproduced 
by cGMP (Williams et ah, 1992; Duman et ah, 1993).
Synaptic plasticity in hippocampus
The neurophysiological basis of learning and memory is thought to involve 
changes in the efficiency of synapses between neurons in a network. Two models 
of activity-dependent synaptic plasticity are long-term potentiation (LTP) and 
long-term depression (LTD).
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Long-term potentiation
The phenomenon of long-term potentiation of synaptic transmission consists of 
potentiation of the size of synaptic potentials for periods in excess of one hour. 
LTP has three properties; input specificity, cooperativity and associativity. It 
seems that the strengthening of the synapses is controlled by the coincident 
activity of both pre and postsynaptic neurons. Collingridge et al., (1988) showed 
that NMDA receptors are essential for the induction of LTP. It was shown that 
during high frequency stimulaion the evoked EPSPs were summated, and the 
Mg^ "^  block of the NMDA receptor channel was removed. Since the activated 
NMDA receptors are permeable to Ca^’*' (Ascher & Nowak, 1988) and LTP 
induction could be blocked by intracellular injection of the Ca^’^ chelator EOT A 
(Lynch et al., 1983), it was assumed that the Ca^ '*' entry through the NMDA 
receptor was the trigger for LTP. Activation of mGluRs result in an increase in 
NMDA receptor-mediated currents and it was suggested that activation on 
mGluRs might reduce the threshold for inducing LTP (Ben-Ari et al., 1992).
Long-term depression
Because of the short history of LTD (Lynch et al., 1977) not much is known about 
the mechanisms involved in this form of synaptic plasticity. LTD was reversibly 
blocked by the NMDA receptor antagonist D-AP5, indicating that LTD is NMDA 
receptor-dependent and suggesting that Ca^ "^  entry through this receptor is 
necessary for its induction (Dudek & Bear, 1992). It was demonstrated that LTD 
is saturable, repeated low frequency stimulation (1 Hz) caused a decrease that 
saturated at 50% (Dudek & Bear, 1992). It has also been revealed that synapses
34
depressed by low frequency stimulation can be potentiated by high frequency 
stimulation and vice versa (Ngezahayo et ah, 1997).
Paired-pulse interactions
Synaptic transmission in the mammalian brain can be regulated in different ways. 
Two examples of this regulation are short-term plasticity of synapses consisting of 
paired-pulse facilitation (PPF) and paired-pulse depression (PPD).
Paired-pulse facilitation
Paired-pulse facilitation (PPF) is a form of short term plasticity in which the 
synaptic response to the test pulse (second stimulus) given rapidly after 
conditioning pulse (first stimulus) is enhanced in comparison to the conditioning 
pulse. The best known hypothesis to explain the mechanism of PPF is the 
presynaptic accumulation of Ca^ "^  after an initial stimulation. Indeed, the first 
pulse induces a small Ca^^ influx that cannot trigger transmitter release itself, but 
remains in the terminal for several hundred milliseconds. This residual Ca^ "^  
combined with Ca^ "^  entering during the second pulse leads to increasing 
transmitter release (Katz & Miledi, 1968; Zucker, 1989; Thomson, 2000). The 
Ca^^ concentration in the presynaptic nerve terminal affects the probability of 
neurotransmitter release. Different studies have suggested that the second of two 
paired action potentials at the neuromuscular junction induces release with higher 
probability than the first one as result of a small but lasting increasing of the 
intracellular Ca^ "^  concentration in the axon terminal. The residual Ca^^ can 
enhance this probability by increasing the fusion of synaptic vesicles with the
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presynaptic membrane and enhancing the number of quanta released by an action 
potential (Katz & Miledi, 1968; Debanne et ah, 1996). Neuromodulators or 
physiological processes that affect transmitter release probability affect paired- 
pulse ratio. Increasing the external Mg^VCa^"  ^ ratio (Davies and Collingridge, 
1993; Lambert & Wilson, 1994; Wilcox & Dichter, 1994) and applying adenosine 
(Lupica et ah, 1992; Higgins & Stone, 1995) decrease the probability of release of 
neurotransmitter during the first action potential and increase the probability of 
release by the second action potential causing higher responses. In the 
hippocampus, PPF of excitatory synaptic potentials in areas CAl and CA3 is 
observed when large numbers of axon are stimulated (Creager et ah, 1980; 
Manabe et ah, 1993), whereas under condition in which the release probability is 
elevated by decreasing the Mg^VCa^"  ^ ratio the PPF is reduced (Nathan et ah, 
1990; Kahle & Cotman, 1993).
Paired-pulse depression
When two action potentials of similar amplitude are elicited in the presynaptic 
cell, the amplitude of the second EPSP and/or population spike is smaller than the 
first one, a phenomenon called paired-pulse depression (PPD).
The mechanism underlying the PPD of inhibitory synaptic transmission is 
unknown. One hypothesis is activation of GABAB autoreceptors (Deisz & Prince, 
1989), but studies of Wilcox and Dichter (1994) has shown that GABAB receptor 
antagonists did not attenuate PPD of unitary IPSPs in pairs of cultured 
hippocampal neurons. An alternative presynaptic mechanism for PPD is a 
transient decrease in the quantal content caused by depletion of the readily
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releasable vesicle pool by the first stimulus (Stevens and Wang, 1995; Debanne et 
ai., 1996).
Postsynaptic mechanisms such as desensitisation of GABAa receptors (Alger,
1991) and a reduced driving force due to intracellular accumulation of 0 1  and/or I
extracellular accumulation of (McCarren and Alger, 1985) might also explain 
the PPD.
In hippocampal slices paired-pulse inhibition has been reported at interstimulus 
intervals less than 40 ms and in the present experiments at less than 20 ms while 
PPF is observed at longer time intervals (Higgins & Stone, 1995; Lynch et al.
1983; Nikbakht & Stone 2000).
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Anatomy of hippocampus
For three reasons, the hippocampus is one of the most studied areas of central 
nervous system. First, it has an easily identifiable structme at the gross and 
histological levels. Secondly, it has been recognized that hippocampus plays a 
basic role in learning and memory. Patients who have had bilateral hippocampal 
removal have suffered from a permanent loss of encoding new information into 
long-term memory. Thirdly, the hippocampus is very susceptible to seizure and is 
very vulnerable to the effects of ischemia and anoxia (Johnston & Amaral, 1998). 
In the brains of mammals the hippocampus is a bilaterally represented stmcture 
that appears as a ridge extending into the lateral ventricle. The outer surface of the 
hippocampus is composed of myelinated fibers and seems white and is called the 
alveus. The hippocampal formation can be divided into the Ammon’s horn, the 
dentate gyrus, subiculum and the entorhinal cortex. Based on Golgi preparations.
the anatomist Lorente de No divided Ammon’s horn into four subfields: (Cornu 
Ammonis) CAi to CA4 . CA4 is no longer used because it referred to the region 
occupied by the polymorphic layer of the dentate gyrus. CAi is equivalent to 
region superior and CA2  and CA3 fields are equivalent to the region inferior. CAi 
and CA3 are separated by a narrow transitional zone, CA2 .
The dentate gyrus contains round, tightly packed neurons called granule cells. The 
dentate gyrus consists of three layers: the granule layer, which is the principal 
layer, the molecular layer, (above the granule layer) and a polymorphic cell layer 
below the granule cell layer (Isaacson, 1987).
In all CA fields below the alveus is the stratum oriens, which contains the basal 
dendrites of the pyramidal cells. The cell bodies are clearly visible under a 
microscope as a dark band. Below this, is the stratum radiatum consisting of the 
apical dendrites of the pyramidal cells and the Schaffer collaterals, which are 
collateral branches from axons of pyramidal cells in the CA3 region.
The functional organisation of the hippocampus has been described in terms of a 
trisynaptic circuit. Information that flows from the neocortex into and out of the 
hippocampus travels in a unidirectional manner through this trisynaptic pathway. 
The entorhinal cortex is considered to be the starting point of the circuit. The 
fibers of the perforant pathway arise from pyramidal cells of entorhinal cortex. 
They pass through the adjoining subicular complex and terminate in the molecular 
layer of the dentate gyms to form the first synapse in the synaptic pathway with 
the dendrites of granule cells in the dentate gyrus. The axons of these granule 
cells are called mossy fibres.
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They leave the dentate gyrus and terminate on the proximal dendrites of the CA3 
pyramidal cells. CA3 pyramidal cells produce branched axons and send their 
axons out of the hippocampus in the fomix. A branch of this axon “the Schaffer 
collateral” forms strong synaptic connections with dendrites in area CAi. Axons 
from CAl pyramidal neurons project heavily to neurons in the subicular complex. 
There is also a major projection from subicular complex to entorhinal cortex to 
close the circuit (Witter, 1989).
Aim
The aim of this work was to obtain more information about the site and 
mechanism of interactions between mGluRs and adenosine receptors in the CAl 
area of rat hippocampal slices and to identify the nature of the adenosine and 
mGluRs involved. Then we have examined whether the effects of GAB An 
receptor-mediated responses were also modulated by activation of mGluRs. The 
time course of the interactions was investigated and a paired-pulse paradigm was 
used to examine the actions of compounds on presynaptic terminals.
The activation of NMDA receptors can lead to the generation of NO. We have 
therefore examined whether NO is able to modify neuronal responses to 
adenosine, since such an action could contribute to the modulation of LTP and to 
the suppression of adenosine responses by activation of NMDA receptors. For 
comparison the actions of another free radical species, superoxide were 
investigated. These aims are represented in figure 1.1 which summarise a 
hypothetical scheme which this thesis will address.
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>■ Known pathways
>■ Unknown steps to be investigated in this thesis
Figure.1.1. This figure illustrates the known pathways and unknown steps to be 
investigated in this thesis including the nature of the metabotropic glutamate 
receptor (mGluR) modulating adenosine responses, the role of phospholipase C 
(PLC) and the role of NO in modulating adenosine and GABAb responses by 
NMDA receptors.
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2. Material and methods
Hippocampal slices
In vitro slices of mammalian CNS tissue were shown to be physiologically viable 
for many hours by Yamamoto and McIIwain (1966). Since then the slice 
preparation has been extensively used for the study of synaptic transmission and 
electrophysiological experiments in the mammalian central nervous system. 
Yamamoto (1972) developed slices of hippocampus that showed good electrical 
activity following intracellular recording (Yamamoto, 1972; Kerkut & Wheal, 
1981).
Advantages of the in vitro slice preparation over in vivo techniques include:
1- Technical simplicity: it is relatively easy to record via extracellular, 
intracellular and whole-cell patchclamp compared with in vivo 
experiments.
2- Control over the condition of the preparation. For example there is no 
blood pressure to monitor and no heart rate to stabilize. Also the variable 
effects of anaesthesia on the intact animal are not a problem in the slice 
preparation.
3- Improved visualization of tissue. The stimulating and recording electrodes 
can be positioned at the desired site under low magnification.
4- Direct access to extracellular space. The ionic composition of the 
extracellular environment can easily be manipulated.
5- Known concentrations of drugs can be applied to the synapse by addition 
to the bathing solution.
The advantage of the slice preparation led increasing numbers of neuroscientists 
to adopt this technique. However, there are also some disadvantages with brain 
slice preparations including:
1“ Slices are separated from their normal sensory input and have no motor 
output. Long feedback loops and some excitatory and inhibitory pathways 
are lost. Some afferents such as noradrenaline, serotonin and acetylcholine 
cannot be activated in hippocampal slices in vitro (Dunwiddie et a l, 
1983).
2- Inevitably, some tissue will be damaged by the slicing process.
3- The tissue is subject to an anoxic period during preparation (Lipton & 
Whittingham, 1979).
4- The ionic environment does not mimic exactly the normal extracellular 
conditions in vivo.
Preparation of hippocampal slices
Male Wistar rats (140-200g) were anaesthetised with an intraperitoneal injection 
of urethane solution (1.3 g.Kg'^). The animals were then killed by cervical 
dislocation, decapitated using a guillotine, and the brain rapidly removed to ice- 
cold and oxygenated artificial cerebrospinal fluid (ACSF). The cerebellum was 
removed and the two cerebral hemispheres were separated with a scalpel blade. 
The hippocampi were then dissected free of surrounding tissue using spatulas and 
cut transversely into slices 450pm thick using a McIIwain tissue chopper. The 
slices were maintained at room temperature on a filter paper in a petridish 
containing a small amount of fresh gassed ACSF. The petridish was kept in an
42
43
incubation chamber at room temperature in an atmosphere of 95% O2 and 5% 
CO2 bubbled through water for at least 1 hour prior to recording.
Composition of ACSF
The composition of the bathing medium, ACSF was (in mM): KH2PO4  2.2, KCl 
2, NaHCOs 25, NaCl 115, CaCh 2.5, MgS0 4  1.2, and glucoselO. It was gassed 
with a mixture of 95% O2  and 5% CO2 to yield a pH of 7.4.
Bath superfusion and application of drugs
Following incubation individual slices were transferred to a 1 ml recording 
chamber using a fine brush and continuously superfused with fresh ACSF by 
gravity at a rate of 3-4 ml/min. The slices were maintained submerged with a thin 
metal bar and bubbled with 95% O2  and 5% CO2 and heated using a 
thermostatically controlled water bath to yield a temperature between 28 C and 
30 C. Drugs were added to the perfusion medium and applied to slices for a 
minimum of 1 0  minutes.
Stimulating and recording
The slices were orthodromically stimulated using a concentric bipolar electrode 
(Clark Electromedical Instruments Ltd) positioned in the stratum radiatum at the 
CA 1/CA2 junction for orthodromic activation of pyramidal cells. Pulses of 300ps 
duration were delivered at 0.05 Hz. Evoked responses were amplified (XIOOO, 
Neurolog) and filtered from DC to a high frequency of 1 KHz. A PC computer 
was used to digitise, analyse and store the responses via a CED (Cambridge
Electronic Design) micro 1401 interface and signal software (CED). Single glass 
microelectrodes were used for recording that filled with IM  NaCl with a tip 
diameter approximately 2-4 |im and resistance approximately 2-5 Mf2.
Paired stimuli were delivered through the same electrode. Extracellular 
population spike potentials and population excitatory postsynaptic potentials 
(EPSP) were recorded from the CAi pyramidal cell layer or the stratum radiatum 
respectively. Slices with P.S.<3mV amplitude or fEPSPs<lmV were not studied. 
Slices were allowed to settle for 1 hour, after which recording were made for 20 
minutes within 15% of the starting potential and only if the potential remained 
stable during that 2 0  minutes was the experiment continued.
Data analysis
Responses were quantified as the amplitude of the population spike in mV 
(difference between the peak of the positive-going synaptic potential and the peak 
of the negative going population spike) and / or the slope of the negative arm of 
the population EPSP.
Results were considered as the percentage of the spike size in the presence of dmg 
compared with control size. The control was calculated as the mean of the 6  
observations immediately preceding start of drug perfusion expressed as a 
percentage of the mean of 30 observations recorded over the previous 10 minutes. 
The effect of added agents was taken as the mean of the final 6  observations made 
during the 10 minutes period of perfusion. When paired-pulse interactions were 
examined, inhibition or facilitation was expressed as the percentage change in the 
second response of a pair compared with the first response.
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Statistical test
Results are presented as mean ± standaid en*or of mean (s.e.m) for n experiments, 
and the statistical significance of any difference assessed by a paired or unpaired 
Student s t-test. The significance of the difference between more than two means 
obtained in the same slices was calculated with repeated measure ANOVA 
followed by the Student-Newman-Keuls test. P values less than 0.05 were 
considered statistically significant.
Chemical agents and drugs
Constituents of ACSF were of Analar grade and dissolved in distilled water to 
prepare fresh ACSF. Baclofen, (RS)-3,5-dihydroxyphenylglycine (DHPG), and 
chelerythrine were dissolved in distilled water to obtain stock solution. Adenosine 
deaminase was dissolved directly in ACSF to give the desired concentration. 
Trans-(±)-l-amino-(lS, 3R)-cyclopentanedicarboxylic acid (ACPD), kynurenic 
acid, xanthine, xanthine oxidase, and (S)-(+)-a-amino-4-carboxy-2- 
methylbenzeneacetic acid (LY367385) were firstly dissolved in lOOmM NaOH 
then distilled water was added to give a stock solution. Dimethyl sulphoxide 
(DMSO) was used to dissolve 2-methyl-6-(2-phenylethenyl)pyridine (SIB), D-2- 
amino-5-phosphono-pentanoic acid (2AP5), 8 -cyclopentyladenosine (CPA), 4-(2- 
[7-amino-2-(2-furyl)[l,2,4]triazolo[2,3a][l,3,5] triazin-5-ylamino]ethyl)phenol 
(ZM24I385), S-Nitroso-N-acetylpenicillamine (SNAP), IH-
[l,2,4]Oxadiazolo[4,3-a]quinoxalin-l-one (ODQ), 2-[l-(3-
Dimethylaminopropyl)indol-3-yl]-3-(indol-3-yl)maleimide (Gf 109203X), and 
(9R, lOS, 12S0-2,3,9,10,11,12-Hexahydro- lO-hydroxy-9-methyl-1 -oxo-9,12- 
epoxy-lH-di-indolo[l,2,3-fg;3',2',r-Kl]pyn’olo[3,4-l][l,6]benzodiazocine-10-
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carboxylic acid, hexyl ester (KT 5720) with the final concentration of DMSO 
never exceeding 0.1%. 5-chloro-N-(6-phenylhexyl)-l-naphthalenesulfonamide 
(SC-9) was dissolved in ethanol. The final concentration of ethanol in perfusing 
solution was less than 0.1%. The solvents DMSO and ethanol were tested at their 
final concentration that had no effect on the potential size.
A majority of drugs were obtained from Tociis Cookson Ltd. Analar grade 
compounds were obtained from BDH chemicals Ltd. UK. Adenosine deaminase, 
xanthine, xanthine oxidase, and haemoglobin were obtained from Sigma chemical 
Co. Ltd. ZM241385 and CPA were purchased from Research Biochemicals 
International. A summary of drug solutions is given in table 2.1.
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Drug Source Solvent Stock solution Used concentration
ACPD Tociis NaOH
lOOmM
lOOmM 20,50 and lOOjiiM
ADA type 
VII
Sigma ACSF O.lIU.ml' O.lIU.ml'^
Adenosine Sigma H2O lOmM 1,2,5,10,20,30 and 
50HM
Antifoam A Sigma ACSF 50PPM 50PPM
DL-AP5 Sigma NaOH
lOOmM
50mM 50\xU
Baclofen Sigma H 2 O 5mM 2[iM
Chelerythrine
Chloride
Tocris H 2 O lOmM 5fxM
CPA RBI DMSO lOmM/
2 0 M-M
20nM
DHPG Tocris H2O lOmM 10|iM
GF109203X Tocris DMSO 5m M /
lOOuM
lOOnM
Hb Sigma ACSF 50|.iM 50p-M
KT5720 Tocris DMSO 0.2mM lOOnM
LY367385 Tocris NaOH
lOOmM
lOOmM lOO^iM
L-NAME Tocris H2O lOOmM lOOj^M
NMDA Sigma H2 O lOmM 4^M
ODQ Tocris DMSO lOmM 10|LiM
SC-9 Tocris Ethanol lOmM 40nM
SIB1893 Tocris DMSO 20mM 40|iM
SNAP Tocris DMSO lOOmM lOOuM
SOD Sigma ACSF 120Uml'^ 120U.ml'^
Xanthine Sigma NaOH
lOOmM
lOOmM lOOOjuiM
Xanthine
oxidase
Sigma ACSF 0.02U.ml‘‘ 0.02U.mr'
ZM241385 RBI DMSO lOmM/
50|xM
50nM
Table,2.1. Showing the compounds used for experiments with their sources, 
solvents, stock solutions and used concentrations.
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Figure2.1. Diagram showing anatomy of the hippocampal formation and the 
placement of the electrodes, (a) The stimulating electrode was positioned in the 
stratum radiatum at the CA 1/CA2 junction. Orthodromic population spikes and 
excitatory postsynaptic potentials were recorded from the stratum pyramidal and 
stratum radiatum respectively using electrodes (b) and (c). (adapted from 
Andersen et al., 1971).
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3. Results
Interactions between adenosine and metabotropic glutamate receptors
The ejfect o f adenosine on orthodromically evoked population spikes 
In normal ACSF, adenosine concentration-dependently decreased or abolished 
the amplitude of orthodromic popoulation spikes evoked from CAl regions in 
hippocampal slices. Concentration response curve for these effects are shown in 
Figure 3.1. The depressant effect of adenosine was reversible and washed out in 5 
to 1 0  minutes.
The concentration -  dependent effect o f ACPD on population spikes 
The effect of ACPD on orthodromic evoked population spikes was investigated in 
hippocampal slices. ACPD was perfused for 10 minutes, and the effect was 
concentration dependent. 20pM ACPD did not induce any change in the size of 
population spike potentials (Fig. 3.2), whereas at 50pM induced a depression of 
38.18% ± 4.43 (Fig. 3.3) and at lOOpM it induced a substantial depression 
(reducing by 8 8 .2 % ± 1.9), and its effect reversed to normal during 10-15 minutes 
washing (Fig. 3.4).
The effect of ACPD at 20, 50 and 100 |iM was also tested on the paired-pulse 
population spikes at 10, 20 and 50 ms interstimulus intervals. ACPD 20 |liM  did 
not modify the paired-pulse ratio at any of the tested intervals (Fig. 3.5). 
Application of ACPD at a concentration of 50p.M produced a significant 
facilitation at 20 ms (Fig. 3.6) and at 100|iM induced a small facilitation but not 
significant at 10, 20 and 50 interstimulus intervals (Fig. 3.7).
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Figure 3.1. Concentration response curve for the inhibitory effect of 
adenosine on orthodromic population spikes evoked from the CAl area in 
hippocampal slices. The stimulus strength was adjusted to 70% of 
maximum. Each point presents the mean ± S.E.M for n = 5 slices. Sample 
records represent Control, adenosine 5|Lt, and wash: Calibration ImV, 
10ms.
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Figure 3.2. Histogram showing the effect of ACPD 20)uiM on orthodromic 
population spikes evoked from CAi region. Each vertical bar shows mean ± 
S.E.M for n = 5 slices.
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Figure 3.3. Histogram showing the effect of ACPD 50|xM on orthodromic 
population spikes evoked from CAi region. Each vertical bar shows mean ± 
S.E.M for n = 6 slices. *** P<0.001
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Figure 3.4. Histogram showing the suppression effect of ACPD lOOpiM on 
orthodromic population spikes evoked from CAi region. Each vertical bar shows 
mean ± S.E.M for n = 5 slices. *** P<0.001
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Figure 3.5. Graph showing the effect of ACPD 20|liM on orthodromic paired- 
pulse population spikes recorded from CAi. Data are shown for interstimulus 
intervals of 10, 20 and 50 ms. ACPD 20pM did not induce any significant change 
in the paired -  pulse ratio. Each point shows the mean ± S.E.M for n = 5 slices.
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Figure 3.6. The effect of ACPD 50|aM on paired -  puise population spikes 
evoked from CAi at interstimulus intervals of 10, 20 and 50 ms. Each point shows 
mean ± S.E.M for n = 6 slices. * P<0.05
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Figure 3.7. The effect of ACPD lOOjiiM on paired -  pulse population spikes 
evoked from CAi at interstimulus intervals of 10, 20 and 50 ms. Each point shows 
mean ± S.E.M for n = 5 slices.
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4;|The Interaction between adenosine and ACPD on single excitatory postsynaptic
potentials
To investigate the effects of metabotropic glutamate receptors on adenosine 
responses a broad spectrum mGluRs agonist ACPD was used. A concentration of 
10 |xM adenosine was chosen for most of these experiments, as it produced an 
approximately 50% inhibition of fEPSPs slope, from which increases or decreases 
could readily be observed and quantified.
In order to determine whether responses to adenosine due to receptor engagement 
decrease in a serial application, a series of adenosine responses was obtained 
before ACPD perfusion (Fig. 3.8). As Figure 3.8 demonstrates there were no 
significant differences between consecutive adenosine responses. The last 
adenosine effect before ACPD was chosen to compare adenosine responses before 
ACPD with adenosine responses after ACPD application. 
Adenosine 10 pM depressed single EPSPs by 59.35% ± 3.39 (p < 0.001; n = 4) 
relative to the initial control size. When applied alone, the non-selective mGluR 
agonist ACPD (100 pM) reduced the fEPSPs slope by 80.83% ± 0.59 (p < 0.001; 
n = 4)(Fig.3.8).
When a series of adenosine responses was obtained, and an application of 
ACPD made after the first of these, it was found that the subsequent responses 
were reduced significantly in size. fEPSPs slope was depressed by only 38.7% ± 
5.59 by an application of adenosine 20 minutes after the ACPD perfusion (p < 
0.01 compared with the initial adenosine response, n = 4). Adenosine responses 
obtained 40 and 60 minutes after the ACPD application remained significantly 
smaller than the initial response (p < 0.05)(Fig. 3.8),
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Paired-pulse interactions
In the paired-pulse paradigm, interstimulus intervals of 10, 20 and 50 ms 
were tested which have previously been shown to generate paired-pulse inhibition 
(at 10 ms) and later paired-pulse potentiation (20 and 50 ms) (Higgins & Stone, 
1996, Nikbakht & Stone 2001). Superfusion of adenosine alone converted the 
inhibition to facilitation at 10 ms and produced a marked increase in facilitation at 
20 and 50 ms (Fig. 3.9). All these changes were highly significant (p < 0.001; n = 
4). Applied alone, ACPD tended to produce a similar shift but this did not reach 
statistical significance. When adenosine was tested 20 minutes following a 10 
minutes application of ACPD, its effects were again reduced significantly (Fig. 
3.9; p < 0.05 compared with the initial adenosine response; n = 4). Subsequent 
responses to adenosine gradually returned towards the original size over a 60 
minutes period as in the study of EPSP slope size described above (Fig. 3.9).
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Figure. 3.8A. Histogram showing the interaction between adenosine lGp.M and 
ACPD lOOpM on the fEPSPs slope in hippocampal slices. The columns 
summarise, respectively, the inhibitory effect of a series of three control 
applications of adenosine alone, the effect of ACPD alone, and three reduced 
responses to adenosine observed 20, 40 and 60 minutes after the application of 
ACPD. The columns indicate the mean ± S.E.M for n = 4 slices. Statistically 
significant differences between columns are indicated as * P<0.05, ** P<0.01.
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Figure 3.8B. Sample records of the orthodromic evoked fEPSPs representing the 
effect of adenosine before and after the superfusion of ACPD. The letters a, b and 
c illustrate control, adenosine lOpM before ACPD and the effect of ACPD 
respectively and d, e and f showing the effect of adenosine 20, 40 and 60 minutes 
after ACPD application and g shows washing after the last adenosine application. 
Calibration: ImV and 10ms
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Figure 3.9. Graph showing the changes of paired-pulse response of fEPSPs slope 
(the % change in the second of a pair of responses relative to the first) for 
interstimulus intervals of 10, 20 and 50 ms. Each point represents mean ± S.E.M 
for n = 4 slices. Only the first adenosine response after ACPD, obtained at 20 
minutes, is shown for clarity. *** P<0.001 for difference between control and 
adenosine before ACPD; # P<0.05 between adenosine responses before and after 
ACPD; ++ P<0.01 between control and ACPD lOOpM.
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Interaction between ACPD and baclofen
In order to determine whether this lasting depression of sensitivity was specific 
for adenosine, similar experiments were performed using ACPD 100 pM and 
baclofen 2 pM. Baclofen initially depressed the single EPSP slope by 59.86% ± 
2.64 (p < 0.001; n = 4) of the basal fEPSPs whereas, after perfusing ACPD, 
baclofen reduced the EPSP slope by only 41.66% ± 3.57 (p < 0.01 compared with 
the initial baclofen response, n = 4), 43.61% ± 1.69 and 47.57% ± 3.42 after 20, 
40 and 60 minutes (Fig. 3.10). ACPD also reduced significantly the decrease in 
paired-pulse inhibition and later paired-pulse facilitation produced by baclofen 
(Fig. 3.11).
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Figure 3.10. Histogram showing the interaction between baclofen (2pM) and 
ACPD lOOpM on the fEPSPs slope in hippocampal slices. The columns 
summarise, respectively, the inhibitory effect of a series of three control 
applications of baclofen alone, the effect of ACPD alone, and three reduced 
responses to baclofen observed 20, 40 and 60 minutes after the application of 
ACPD. The columns indicate the mean ± S.E.M for n = 4 slices. Statistically 
significant differences between columns are indicated as * P<0.05, ** P<0.01.
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Figure 3.11. Graph showing the changes of paired-pulse response of fEPSPs 
slope (the % change in the second of a pair of responses relative to the first) for 
interstimulus intervals of 10, 20 and 50 ms. Each point represents mean ± S.E.M 
for n = 4 slices. Only the first baclofen response after ACPD, obtained at 20 
minutes, is shown for clarity. P<0.001 for difference between control and 
baclofen responses before ACPD; # P<0.05 between baclofen responses before 
and after ACPD; + P<0.05 between control and ACPD lOOpM.
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Identification o f metabotropic glutamate receptors
In order to deteimine whether group I mGluRs were responsible for the effect of 
ACPD, the selective agonist DHPG was used. Before DHPG, adenosine 10 pM 
depressed EPSP size by 58.74% ± 3.32 of the basal level (p < 0.01; n = 5) in this 
series of experiments. DHPG (10 pM) alone decreased the EPSP slope by 
40.18% ± 4.29 (p < 0.001; n = 5). After perfusing DHPG 10 pM, the responses to 
adenosine were reduced significantly after 20 and 40 minutes respectively 
(Fig.3.12).
Adenosine at 10 pM removed any early paired-pulse inhibition and enhanced later 
facilitation (p < 0.001; n = 5). DHPG had no significant effect alone, but it 
reduced the effect of adenosine at both the 10 and 20 ms stimulus intervals (Fig. 
3.13). As in the earlier studies above, sensitivity to adenosine gradually recovered 
so that, after 60 minutes, responses were not different from the original size.
Interaction between baclofen and DHPG on single and paired -  pulse excitatory 
postsynaptic potentials
In order to determine whether the effects of group I mGluRs agonist is specific for 
adenosine, interactions between DHPG and GAB As agonist baclofen were 
examined. Baclofen (2 pM) depressed the single EPSP slope by 69.11% ± 3.37 of 
the basal potential (p < 0.001; n = 4) whereas at 20 and 40 minutes after perfusion 
with DHPG, it reduced EPSP slope significantly less (Fig.3.14). In the paired- 
pulse experiments, DHPG tended to reduce the effect of baclofen, though this did 
not reach significance (Fig. 3.15).
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Figure. 3.12A. Histogram showing the interaction between adenosine lOpM and 
DHPG lOpM on the fEPSPs slope in hippocampal slices. The columns 
summarise, respectively, the inhibitory effect of a series of three control 
applications of adenosine alone, the effect of DHPG alone, and three reduced 
responses to adenosine observed 20, 40 and 60 minutes after the application of 
DHPG. The columns indicate the mean ± S.E.M for n = 4 slices. Statistically 
significant differences between columns are indicated as * P<0.05, ** P<0.01.
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Figure 3.12B. Sample records of the orthodromic evoked population EPSP 
showing the effect of adenosine before and after the superfusion of DHPG. The 
letters a, b and c illustrate control, adenosine lOfxM before DHPG, and the effect 
of DHPG respectively and d, e and f showing the effect of adenosine 20, 40 and 
60 minutes after DHPG application and g shows washing after the last adenosine 
application. Calibration: ImV and 10ms.
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Figure 3.13A. Graph showing the changes of paired -  pulse response of fEPSPs 
slope (the % change in the second of a pair of responses relative to the first) ) for 
interstimulus intervals of 10, 20 and 50 ms. Each point represents mean ± S.E.M 
for n = 4 slices. Only the first adenosine response after DHPG, obtained at 20 
minutes, is shown for clarity. *** P<0.001 for difference between control and 
adenosine before DHPG; # P<0.05 between adenosine responses before and after 
DHPG; + P<0.01 between control and DHPG lOOjiM
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Figure 3. 13B. Records of the population fEPSPs during paired-pulse 
interactions, showing control responses at interstimulus intervals of (a) 10ms, (b) 
20ms, (c) 50ms. The lower traces (d-F) illustrate the effect of adenosine, lOpiM at 
the same stimulus intervals. Calibrations: ImV and 10ms
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Figure 3.14. Histogram showing the interaction between baclofen 2p,M and 
DHPG lOpM on the fEPSPs slope in hippocampal slices. The columns 
summarise, respectively, the inhibitory effect of a series of three control 
applications of baclofen alone, the effect of DHPG alone, and three reduced 
responses to baclofen observed 20, 40 and 60 minutes after the application of 
DHPG. The columns indicate the mean ± S.E.M for n = 4 slices. Statistically 
significant differences between columns are indicated as * P<0.05.
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Figure 3.15. Modulation of orthodromic evoked fEPSPs by baclofen 2\xM, DHPG 
lOfiM and baclofen 20 minutes after DHPG application. Each point represents 
mean ± S.E.M for n = 4 slices. * P<0.05 and ** P<0.01 for difference between 
control and baclofen.
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Interaction between adenosine and DHPG on single and pa ired -pu lse  excitatory 
postsynaptic potentials in the presence o f receptor sub -  type antagonists 
Two selective antagonists were used to assess the involvement of subtypes of the 
group I mGluRs. (S)-(+)-a-amino-4-carboxy-2-methylbenzeneacetic acid 
(LY367385), an antagonist at mGluia receptors was supeifused at 100 |iM as 
described by Mannaioni et a l, 2001. This compound had no effect itself on the 
baseline size of the EPSP slope, and did not modify sensitivity to adenosine. It 
did, however, prevent the direct inhibitory activity of DHPG itself on EPSP slope 
(Fig. 3.16) and on paired-pulse interactions (Fig 3.17). It also prevented 
completely the depression by DHPG of adenosine sensitivity, so that the effect of 
adenosine on EPSP slope and paired-pulse interaction was not different from that 
recorded before the superfusion of DHPG (Figs. 3.16, 3.17).
The mGlus antagonist 2-methyl-6-(2-phenylethenyl)pyridine (SIB 1893) at 
40 p,M did not prevent the reduction of adenosine sensitivity by DHPG, either on 
EPSP slope(Fig. 3.18) or paired-pulse interactions (Fig. 3.19).
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Figure 3.16. Histogram showing the interaction between adenosine lOfiM and 
DHPG 10 |liM  in the presence of (S)-(+)-a-amino-4-carboxy-2- 
methylbenzeneacetic acid (LY367385) IGOpM, an antagonist at mGluia receptors, 
on the fEPSPs slope in hippocampal slices. Each vertical bar represents mean ± 
S.E.M for n = 4 slices.
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Figure 3.17. Graph showing the interaction between adenosine lOjiM and DHPG 
lOjiM in the presence of LY367385 100p.M on the paired-pulse responses of 
fEPSPs in CAi area of hippocampus for interstimulus intervals of 10, 20 and 50 
ms. Each point represents mean ± S.E.M for n = 4 slices. *** P<0.001 and ** 
P<0.01 between control and adenosine in the presence of LY367385 before and 
after DHPG.
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Figure 3.18. Histogram showing the effect of adenosine lOjaM and DHPG lOpM 
in the presence of the mGlus antagonist 2-methyl-6-(2-phenylethenyl)pyridine 
(SIB 1893) at 40 pM on fEPSPs evoked from the CAI region of hippocampal 
slices. Each vertical bar represents mean ± S.E.M for n = 4 slices. * P<0.05
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Figure 3.19. Modulation of orthodromic evoked paired-pulse fEPSPs by 
adenosine lOjiM and DHPG lOjiM in the presence of The mGlug antagonist 2- 
methyl-6-(2-phenylethenyl)pyridine (SIB 1893) at 40 |xM. Each point represents 
mean ± S.E.M for n = 4 slices. *** P<0.05 for difference between control and 
adenosine in the presence of SIB 1893. # P<0.05 for difference between adenosine 
before and after DHPG in the presence of SIB 1893. + P<0.05 between control and 
DHPG in the presence of SIB 1893.
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Interaction between adenosine and DHPG on single and paired -  pulse excitatory 
postsynaptic potentials in the presence ofNMDA antagonist.
In order to examine the possible involvement of NMDA receptors in the 
interactions between adenosine and metabotropic agonists, the experiments were 
repeated in ^he presence of D-2-aminO“5-phosphono-pentanoic acid, 50 |iM 
(2AP5). This compound prevented the suppression of adenosine responses after 
perfusion with DHPG, assessed both as the change in EPSP slope (Fig. 3.20) and 
as the change of paired-pulse inhibition (Fig. 3.21).
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Figure 3.20. Histogram showing the effect of adenosine 10|lIM  and DHPG 10|iM 
in the presence of D-2-amino-5-phosphono-pentanoic acid (2AP5) 50|uiM on 
fEPSPs from the CAI region of hippocampal slices. Each vertical bar represents 
mean ± S.E.M for n = 4 slices. The columns summarise, respectively, the lack of 
effect of DHPG in the presence of 2AP5 and the normal response to adenosine 
observed 20 minutes after the application of DHPG.
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Figure 3.21. Modulation of orthodromic evoked paired-pulse fEPSPs by 
adenosine lOpM and DHPG iOjiM in the presence of 2AP5 50p.M. Each point 
represents mean ± S.E.M for n = 4 slices. *** P<0.05 for difference between 
control and adenosine in the presence of 2AP5 before and after DHPG lOpM 
application.
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Involvement o f protein kinase C
The protein kinase C inhibitors chelerythrine and 2 -[l“(3-dimethylaminopropyi) 
indol-3-yl]-3-(indol-3-yl) maleimide (GF109203X) were used to assess the 
involvement of protein kinase C in the effects of the mGluR ligands. Both were 
applied for 10 minutes before, during and following the application of DHPG. At 
a concentration of 5 jiM, chelerythrine had no significant effect of its own but did 
prevent the suppression of adenosine responses by DHPG on the single EPSP 
slope (Fig. 3.22). In addition, chelerythrine prevented the changes of paired-pulse 
interactions (Fig. 3.23), such that these remained at the initial control size for up 
to 60 minutes after the application of DHPG.
At lOOnM GF109203X (as described by Toullect et ai., with IC5 0  from 5 to 70 
nM) similarly had no significant effect alone or on the responses to adenosine, but 
did prevent the suppression of adenosine responses by DHPG on the single EPSP 
slope (Fig.3.24). Furthermore, GF109203X prevented the changes by DHPG of 
adenosine effects on paired-pulse interactions (Fig. 3.25), such that these 
remained at the initial control size for up to 60 minutes after the application of 
DHPG.
In contrast, the protein kinase A inhibitor (9R, lOS, 12S)-2,3,9,10,11,12- 
hexahydro-1 Ohydroxy-9-methyl-1 -oxo-9, 12-epoxy-IH-di-indolo [1,2,3-
fg:3 ',2 ,1 '-kl] pyn’olo[3,4-l][ 1,6]benzo-diazocine-10-carboxylic acid hexyl ester 
(KT5720) lOOnM did not interfere with the interaction between DHPG and 
adenosine on both single(Fig. 3.26) and paired-pulse interaction (Fig. 3.27).
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Application o f protein kinase C activator
As a further test of the possible role of PKC, the PKC activator 5-chloro-N-(6- 
phenylhexyl)-l“naphthalenesulfonamide (SC-9) lOjiM (as described by Ito et ah, 
Km value of PKC activated was 5.8pM, so we selected lOpM for better responses) 
was superfused for 10 minutes before, during and after a test application of 
adenosine. This resulted in a significant reduction in the size of response to 
adenosine, examined on a single EPSP slope (Fig.3.28) or on paired-pulse 
interactions (Fig. 3.29).
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Figure 3.22. Histogram showing the effect of adenosine lO i^M and DHPG lOjiM 
in the presence of chelerythrine 5|xM on fEPSPs evoked from the CAi region of 
hippocampal slices. Each vertical bar represents mean ± S.E.M for n = 4 slices.
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Figure 3.23. Graph showing the interaction between adenosine lOpM and 
DHPG lOjLiM in the presence of the PKC inhibitor chelerythrine 5pM on 
the paired-pulse fEPSPs recorded from CAi for interstimulus intervals of 
10, 20 and 50 ms. Each point represents mean ± S.E.M for n = 4 slices. ** 
P<0.01, *** P<0.001 and between control and adenosine in the presence 
of chelerythrine before DHPG.
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Figure 3.24. Histogram showing the influence of GF 109203X (lOOnM) on the 
interaction between adenosine lOpM and DHPG lOpM on the fEPSPs slope in 
hippocampal slices. Normal responses to adenosine were observed 20, 40 and 60 
minutes after the application of DHPG + GF 109203X. Each vertical bar 
represents mean ± S.E.M for n = 4 slices. *** P<0.001.
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Figure 3.25. Modulation of orthodromie evoked paired-pulse fEPSPs by 
adenosine lOfiM and DHPG lOjaM in the presence of PKC inhibitor GF109203X 
lOOnM. Each point represents mean ± S.E.M for n = 4 slices. Only the first 
adenosine response after DHPG, obtained at 20 minutes, is shown for clarity. * 
P<0.05, ** P<0.01, *** P<0.001 for difference between controls and adenosine 
before DHPG. + P<0.05 between controls and DHPG.
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Figure 3.26. Histogram showing the influence of PKA inhibitor KT5720 lOOnM 
on the interaction between adenosine 10|xM and DHPG lOjxM on fEPSPs slope in 
hippocampal slices. The columns indicate the mean ± S.E.M for n = 4 slices. * 
P<0.05
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Figure 3.27. Modulation of orthodromie evoked paired-pulse fEPSPs by 
adenosine 10|4M and DHPG lO^M in the presence of PKA inhibitor KT5720 100 
nM, Each point represents mean ± S.E.M for n = 4 slices. Only the first adenosine 
response after DHPG, obtained at 20 minutes, is shown for clarity. *** P<0.001 
for difference between controls and adenosine before DHPG. # P<0.05 between 
adenosine before and after DHPG in the presence of KT5720. +++ P<0.001 
between controls and DHPG + KT5720.
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Figure 3.28. Histogram showing the influence of PKC activator 5-chloro-N-(6- 
phenylhexyl)-I-naphthalenesulfonamide (SC-9) 10|liM on the effects of adenosine 
IO|xM on the fEPSPs slope in hippocampal slices. The columns indicate the mean 
± S.E.M for n = 4 slices. ** P<0.01
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Figure 3.29. Modulation of orthodromic evoked paired-pulse fEPSPs by 
adenosine lOjxM and adenosine 4- SC-9 lOjiM (PKC activator). Each point 
represents mean ± S.E.M for n = 4 slices. * P<0.05, ** P<0.01 for difference 
between controls and adenosine before SC-9. # P<0.05 between adenosine before 
and after SC-9.
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Identification o f  adenosine receptors
In order to determine whether the effect of mGluR activation on adenosine 
responses was mediated via an action on A% adenosine receptors, experiments 
were performed in which slices were superfused with adenosine deaminase 
(O.lU.mr^). Adenosine deaminase was included to remove endogenous adenosine 
from both A1 and A2 adenosine receptors and thus ensure that receptors were 
activated only by experimentally receptor-selective compounds. Ai receptors were 
activated using the selective agonist 8-cyclopentyladenosine (CPA). When 
superfused alone, CPA 20 nM significantly depressed the EPSP slope (Fig. 3.30) 
and enhanced paired-pulse facilitation (Fig. 3.31) as has been reported in previous 
studies (Nikbakht and Stone, 2001). Following the application of DHPG (10 |iM), 
the response to CPA was reduced significantly on EPSP slope (p < 0.05, n = 
4)(Fig. 3.30) and paired-pulse responses (Fig. 3.31). The ability of the deaminase 
activity to remove adenosine was confirmed by showing its prevention of the 
responses to adenosine in separate experiments (Fig. 3.32 & Fig. 3.33).
The possible involvement of adenosine A2 A receptors was then examined by 
including the selective antagonist ZM241385. When supeifused at a concentration 
of 50 nM, which should be selective for the A2A receptor subtype, this agent had 
no effect of its own on potential size and did not modify the depression of EPSP 
slope (Fig. 3.34) or paired-pulse inhibition induced by adenosine or DHPG (Fig. 
3.35). Following the application of DHPG, however, adenosine responses were 
still reduced compared with their initial level, indicating that ZM241385 had not 
modified the antagonistic effect of DHPG.
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Figure 3.30. Histogram showing the effect of CPA 20nM and DHPG 10|xM in the 
presence of adenosine deaminase 0.1 lU.mP* on fEPSPs evoked from the CAi 
region of hippocampal slices. Each vertical bar represents mean ± S.E.M for n = 4 
slices. * P<0.05
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Fig. 3.31. Modulation of orthodromic evoked paired-pulse fEPSPs by CPA 20nM 
and DHPG lOpM in the presence of adenosine deaminase 0.1 IU .m r\ Each point 
represents mean ± S.E.M for n = 4 slices. *** P<0.05 for difference between 
control and CPA before DHPG. # P<0.05 for difference between CPA before and 
after DHPG. + P<0.05, ++ P<0.01 for difference between control and DHPG.
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Figure 3.32. Histogram showing responses to adenosine lOpM and the prevention 
of these responses in the presence of adenosine deaminase 0. HU.mil ' on fEPSPs 
evoked from the CAI region of hippocampal slices. Adenosine deaminase present 
during the second and third applications. Each vertical bar represents mean ± 
S.E.M for n = 4 slices. *** P<0.001
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Figure 3.33. Modulation of orthodromic evoked paired-pulse fEPSPs by 
adenosine 10p,M in the presence of adenosine deaminase 0.1 IU.ml"\ Data are 
shown for interstimulus intervals of 10, 20 and 50 ms in control slices and the 
effect of adenosine before, during and after superfusion with ADA. Each point 
represents mean ± S.E.M for n = 4 slices.
P<0.001.
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Figure 3.34. Histogram showing the interaction between adenosine 10|lIM and 
DHPG lOpM in the presence of ZM241385 50nM on fEPSPs evoked from the 
CAI region of hippocampal slices. Each vertical bar represents mean ± S.E.M for 
n = 4 slices. * P<0.05
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Fig. 3,35. Modulation of orthodromie evoked paired-pulse fEPSPs by adenosine 
lOp^M and DHPG 10|4M in the presence of ZM241385 50nM. Only the first 
adenosine response after DHPG, obtained at 20 minutes, is shown for clarity. 
Each point represents mean ± S.E.M for n = 4 slices. P<0.001 and ** P<0.01 
between controls and adenosine before DHPG in the presence of ZM241385. # 
P<0.05 and ## P<0.01 between adenosine before and after DHPG in the presence 
of ZM241385.
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Nitric oxide suppression of presynaptic responses to adenosine
Interaction between adenosine and SNAP on evoked excitatory post synaptic 
potentials in hippocampal slices
The activation of NMDA receptors can suppress the inhibitory action of 
adenosine on synaptic transmission in hippocampal slices (Bartrup & Stone, 1988, 
1990; Nikbakht & Stone, 2001). We have now explored the possible involvement 
of NO in this interaction. A concentration of 10//M adenosine was selected for 
these experiments as previous work has shown that this consistently results in 
approximately 60% depression of evoked potentials that allows an increase or 
decrease of response slope to be detected. Adenosine lOyt/M depressed single 
EPSPs by 60.14% ± 2.58 (p < 0.001; n = 5) of the initial control size. When 
SNAP was superfused at a concentration of 10//M, no significant change was 
observed either in baseline EPSP slope or in the responses to two applications of 
adenosine obtained 10 mins apart, which reduced fEPSPs slope by 55.9% ± 5.69 
and 53.24% ± 4.3 (n = 3)(Fig. 3.36).
In contrast, the supeifusion of SNAP at a higher concentration of 100//M 
induced a long-lasting potentiation of fEPSPs slope which attained a level of 
141% ± 10.98 (n = 4) compared with the baseline slope (NO-LTP). Before the 
application of SNAP, adenosine reduced fEPSP slope by 54.46% ± 5.6 (n = 4) of 
the control size, whereas during the application of SNAP two adenosine responses 
obtained 10 mins apart were significantly smaller, with reductions of 30.5% ± 
3.29 and 20.6% ± 2.02 (n = 4) respectively (Fig. 3.37a & 3.37b).
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Paired-pulse interactions
An interstimulus intervals of 10, 20, 50 ms, Paired-pulse stimulation induced the 
pattern of paired-pulse inhibition at 10 ms and facilitation at 20 and 50 ms 
reported previously (Higgins and Stone, 1996; Nikbakht and Stone, 2000). 
Adenosine alone and with SNAP lOjiiM changed the inhibitory component to 
facilitation at 10 ms interstimulus interval and increased the facilitation at 20 and 
50 ms interstimulus intervals (Fig. 3.38). Meanwhile, when perfused with SNAP 
lOO^M, this concentration was sufficient to reduce significantly the effects of 
adenosine on paired-pulse phenomena (Fig. 3.39). Induction of NO-LTP after 
perfusion of SNAP lOOjiM modified the paired-pulse interactions at 10 and 20 ms 
interstimulus intervals.
Ejfect o f EPSP size on adenosine sensitivity
In order to determine whether the reduction of adenosine response is due to LTP 
or NO, the stimulus was reduced to restore potential size to control level after the 
induction of LTP by NO. The reduction of adenosine response (41.47% ± 4.79, 
P<0.05 n=3) was still observed on single and paired-pulses EPSP (Fig. 3.40 & 
Fig. 3.41). Adenosine alone decreased the fEPSPs slope by 57.94 ± 5.98 (n=3).
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Figure 3.36. Histogram showing the interaction between adenosine lO^tM and 
SNAP 10|xM on fEPSPs evoked from the CAI region of hippocampal slices. Each 
vertical bar represents mean ± S.E.M for n = 3 slices. *** P<0.001
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Figure 3.37a. Histogram showing the interaction between adenosine IG^iM and 
SNAP100p,M on fEPSPs evoked from the CAI region of hippocampal slices. 
Each vertical bar represents mean ± S.E.M for n = 4 slices. * P<0.05, ** P<0.01, 
*** P<0.001
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Fig. 3.37b. The original records of orthodromic evoked excitatory postsynaptic 
potentials illustrate the interaction between adenosine and SNAP, (a) is a control 
EPSPs, (b) the effect of adenosine lOpM, record (c) shows the reduced response 
to adenosine in the presence of SNAP lOOjxM (first response), (d) is taken in the 
presence of SNAP lOOpM alone, and (e) the reduced effect of adenosine in the 
presence of SNAP lOOpM (second response).
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Figure 3.38. Modulation of orthodromic evoked paired-pulse fEPSPs by 
adenosine lOpM in the presence of SNAP lOpM. Data are shown for 
interstimulus intervals of 10, 20 and 50 ms in control slices and the effect of 
adenosine alone, and Adenosine + SNAP. Each point represents mean ± S.E.M 
for n = 3 slices, *** P<0.001
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Figure 3.39. Modulation of orthodromic evoked paired-pulse fEPSPs by 
adenosine IOjliM in the presence of SNAP 100p,M. Data are shown for 
interstimulus intervals of 10, 20 and 50 ms in control slices and the effect of 
adenosine alone, SNAP alone and Adenosine + SNAP. Each point represents 
mean ± S.E.M for n = 4 slices. P<0.001 between adenosine and control, ++ 
P<0.01 between adenosine and adenosine + SNAP, ## between adenosine and 
adenosine +SNAP, & P<0.05 between control and SNAP.
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Figure 3.40. . Histogram showing the interaction between adenosine 10|xM and 
SNAP IGOjaM on fEPSPs evoked from the CAI region of hippocampal slices with 
stimulus strength adjusted to restore potentials to control size. Each vertical bar 
represents mean ± S.E.M for n = 3 slices.
* P<0.05, ** P<0.01, ***P<0.001
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Figure 3.41. Modulation of orthodromie evoked paired-pulse fEPSPs by 
adenosine lOpM alone, adenosine + SNAP lOOpM and adenosine + SNAP 
lOOpM after reducing stimulus strength to restore potentiated EPSP size to control 
level. Data are shown for interstimulus intervals of 10, 20 and 50 ms in control 
slices and the effect of adenosine alone, and Adenosine + SNAP, and adenosine 
+SNAP after reducing stimulus. Each point represents mean ± S.E.M for n = 3 
slices. *** P<0.001 between adenosine and control, + P<0.05 between adenosine 
and adenosine + SNAP, # P<0.05 between adenosine and adenosine + SNAP after 
reducing stimulus, ## P<0.01 between adenosine and adenosine + SNAP after 
reducing stimulus.
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Paired-pulse interactions
In the control state a small degree of paired-pulse depression was observed at the 
10 ms interval, with potentiation of the second spike at the longer intervals. The 
effect of SNAP 100//M in the presence of adenosine deaminase 0.1 lU.ml'^ was to 
induce a significant inhibition at 10, 20, 50 ms intervals. Paired-pulse inhibiton at 
the 10 ms interval was still significant after 10 min. of washing (Fig. 3.43).
The ejfects o f 2AP5 on NO-LTP
We then examined whether the LTP induced by SNAP involved the activation of 
NMDA receptors, since NMDA receptors have previously been shown to reduce 
sensitivity to adenosine (Nikbakht and Stone 2001). Superfusion with 2-amino-5-
Role o f  adenosine blockade in SNAP-induced LTP
'IIn order to determine whether the induction of LTP with SNAP was itself partly :J:
$due to the reduction of adenosine sensitivity, adenosine deaminase was applied at
;•
0.1 IU .m r\ Adenosine deaminase at this concentration has already been shown 
sufficient to remove adenosine added to the slices. Adenosine deaminase itself s
had no effect on EPSP slope. When the slices were also perfused with SNAP at 
lOOywM for 10 min, SNAP induced a long-term potentiation of EPSP slope which 
attained a maximum level of 165.3% ± 6.6 (n = 4) of baseline, and remained 
elevated at 141.55% ± 5.35 of baseline after 40 min of washing with ACSF 
containing adenosine deaminase alone (Fig. 3.42). These values were not 
significantly different from those obtained in response to SNAP in the absence of 
adenosine deaminase.
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phosphono-pentanoic acid (2AP5) at 50mM did not prevent the SNAP-induced 
increase of fEPSP slope which attained a level of 140.87% ± 10.21 (n = 4) of the 
control potential size after 40 min. Similarly, 2AP5 did not prevent the reduction 
of adenosine response by NO (24.53% + 9.08 and 31.43% ± 5.44, n = 4, P < 0.05) 
compared with the control (adenosine plus AP5) response size of 53.75% ± 5.56, 
(n = 4) (Fig. 3.44).
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Figure 3.42. Histogram showing the effect of SNAP lOOjxM in the presence of 
adenosine deaminase O.lIU.ml'^ on fEPSPs evoked from the CAl region of 
hippocampal slices. Each vertical bar represents mean ± S.E.M for n = 4 slices. 
*** P<0.001
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Figure 3.43. Modulation of orthodromic evoked paired-pulse fEPSPs by SNAP 
lOOjaM in the presence of adenosine deaminase O.HU.mr\ Each point represents 
mean ± S.E.M for n = 4 slices. *** P<0.001, ** P<0.01 between control and 
SNAP + ADA, # P<0,05 between control and washing after 10 min.
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Figure 3.44. Histogram showing the effect of AP5 50|aM on NO-LTP and 
interactions between adenosine and SNAP 100p,M on fEPSPs evoked from the 
CAl region of hippocampal slices. Each vertical bar represents mean ± S.E.M for 
n = 4 slices. * P<0.05, ** P<0.01, *** P<0.001
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Interaction between SNAP and baclofen
In order to determine the specifity of interaction between adenosine and NO, the 
interaction between the GAB Ab agonist baclofen and NO was investigated.
The GABAb receptor agonist baclofen at 2pM depressed the fEPSP slope by 
65.88% ± 4.06 (n = 5). During the first few minutes of perfusion with SNAP at 
lOOjaM, the depression by baclofen remained unchanged at 63.0% ± 4.70 of 
baseline slope. A subsequent application of baclofen 10 mins later, however, was 
significantly reduced to 40.9% ± 8.62 (n = 5) (Fig. 3.45).
Paired-pulse interaction
In the paired-pulse paradigm, superfusion of baclofen 2p,M alone reversed the 
inhibition to facilitation at 10 ms and increased significantly the facilitation at 20 
and 50 ms. SNAP at lOOfxM had no effect on paired-pulse interactions and did not 
modify the size of the first response to baclofen. At the 10 and 20 ms 
interstimulus intervals, a second response to baclofen obtained 10 mins later was 
significantly smaller than the controls (Fig. 3.46).
Effect o f EPSP size on baclofen sensitivity
In order to determine whether the reduction of baclofen response is due to LTP or 
NO, the stimulus was changed to restore potential size to control level after 
induction of NO-LTP. No significant change was observed in baseline fEPSP 
slope and response between the first baclofen application (66.1% ± 3.48, n=4) and 
baclofen after SNAP and reduced stimulus strength in single fEPSP (63.12% ± 
2.59, n=4) (Fig. 3.47) and paired-pulse interactions (Fig. 3.48).
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Figure 3.45. Histogram showing the interaction between baclofen 2|aM and 
SNAP lOOpM on fEPSPs evoked from the CAl region of hippocampal slices. 
Each vertical bar represents mean ± S.E.M for n = 4 slices. ** P<0.01, *** 
P<0.001
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Figure 3.46. Modulation of oithodromic evoked paired-pulse fEPSPs by baclofen 
2pM and SNAP lOOfiM. Each point represents mean ± SE.M  for n ~ 4 slices. 
P<0.001 control and baclofen and also between control and baclofen 4- SNAP 
before inducing LTP. + P<0.05 between baclofen and baclofen -f SNAP after 
inducing LTP.
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Figure 3.47. Histogram showing the interaction between baclofen 2p,M and 
SNAPlOOpM after reducing the stimulus for restoring the potential size to control 
levels on fEPSPs evoked from the CAl region of hippocampal slices. Each 
vertical bar represents mean ± S.E.M for n = 4 slices. *** P<0.001
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Figure 3.48. Modulation of orthodromic evoked paired-pulse fEPSPs by baclofen 
2pM and SNAP 100|xM after reducing the stimulus strength to restore the 
potential response size to control levels. Each point represents mean ± S.E.M for n 
= 4 slices. *** P<0.001 control and baclofen and also between control and 
baclofen + SNAP.
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The effect o f guanylyl cyclase inhibitor on interaction between adenosine and 
SNAP
The guanylyl cyclase inhibitor ODQ lOpM (as showed with Boulton et ah, 1995) 
was applied to determine whether the effects of NO were mediated via the 
activation of guanylyl cyclase.
The effect of SNAP lOOpM on adenosine responses was blocked by application of 
the guanylyl cyclase inhibitor ODQ 10 juM.The first response to adenosine alone 
was 58.71% ± 2.23, n=5 and the first and second adenosine responses to SNAP in 
the presence of ODQ were (49.38 ± 3.41 n=5) and (51.3 ± 3.03 n=5) (Fig.3.49).
Involvement o f adenosine A1 receptors
Although the presynaptic inhibitory effects of adenosine are generally considered 
to be mediated by A1 receptors, we have also examined the interaction between 
NO and the A1 receptor selective agonist, N6-cyclopentyladenosine (CPA). At 
20nM, CPA significantly suppressed the fEPSP slope (40.90% ± 4.82 n = 5, P < 
0.001), but this effect was substantially and significantly reduced in the presence 
of SNAP lOOjuM (Fig. 3.50). Wash out of CPA took 20-25 min to obtain a stable 
recovery.
Alternative free radicals
Since NO is a free radical, and NMDA receptor activation is known to 
result in the generation of free radicals such as superoxide in addition to NO, we 
considered the possibility that its effects might be non-specific and shared by any 
free radical species producing oxidative damage to the adenosine A1 receptor. We
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therefore turned to an examination of the superoxide generating system of 
xanthine plus xanthine oxidase (X/XO).
Interaction between adenosine and xanthine/xanthine oxidase on single pulse and 
paired-pulse excitatory postsynaptic potentials
The activation of NMDA receptors can generate superoxide anions (Palumbo et 
ah, 1992). We have, therefore, examined whether superoxide could modify 
adenosine responses. The superfusion of xanthine (100//M) / xanthine oxidase 
(0.02U.mr^) (X/XO) during the application of adenosine resulted in a significant 
suppression of the responses to adenosine (32.6% ± 3.02, n=5, P<0.05) while 
adenosine alone depressed the EPSPs slope by 48.68% ± 4.12 (n=5) of the control 
size. Washing with X/XO after application of adenosine and X/XO induced a 
long-term potentiation of EPSP slope which attained a level of 126.2% ± 6.17 
(n=5) after lOmin of washing relative to the control EPSP slope. The effects of 
adenosine in the presence of X/XO 100//M/0.02U.ml'^ were depressed after 
induction of NO-LTP (28.46% ± 4.15, n=5, P<0,001) using single pulses and 
paired-pulses EPSP.
Effect o f EPSP size on adenosine sensitivity
In order to determine whether the reduction of adenosine response is due to LTP 
or X/XO, the stimulus was changed to the control level after induction of LTP. 
Reduction of adenosine responses was still observed (25.6% ± 5.91, P<0.001, 
n=5) whereas adenosine alone decreased the EPSP slope by 48.86% ± 4.53 n=5
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(Fig. 3.51). The reduction of adenosine effect on paired-pulse activity was also 
still observed (Fig. 3.52).
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Figure 3.49. Histogram showing the interaction between adenosine lOpM and 
SNAPlOOpM in the presence of ODQ lOpM on fEPSPs evoked from the CAl 
region of hippocampal slices. Each vertical bar represents mean ± S.E.M for n = 4 
slices. *** P<0.001
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Figure 3.50. Histogram showing the interaction between the A1 receptor selective 
agonist CPA 20nM and SNAPlOOpM on fEPSPs evoked from the CAl region of 
hippocampal slices. Each vertical bar represents mean ± S.E.M for n = 5 slices. ** 
P<0.01, ***P<0.001
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Figure 3.51. Histogram showing the interaction between adenosine lOjiM and 
xanthine 100|xM/xanthine oxidase O.OZUml'  ^ after reducing stimulus strength to 
restore the potential responses size to control level on fEPSPs evoked from the 
CAl region of hippocampal slices. Each vertical bar represents mean ± S.E.M for 
n = 5 slices. ** P<0.01, *** P<0.001
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Figure 3.52. Modulation of orthodromic evoked paired-pulse fEPSPs by 
adenosine lOpM and xanthinelOOpM/xanthine oxidase 0.02Umr^ with stimulus 
strength adjusted to restore potentials to control size. Each point represents mean 
± S.E.M for n = 4 slices. P<0.001 control and adenosine, # P<0.05 between 
adenosine alone and adenosine +X/XO (first response), + P<0.05, ++ P<0.01 
between adenosine and adenosine + X/XO (second response).
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Application o f  Xanthine and xanthine oxidase separately
In order to determine which compound was involved in the X/XO effects xanthine 
and xanthine oxidase were applied separately. Xanthine lOOpM alone could 
induce LTP in the slices (125.4% ± 4.87, n=4). Adenosine alone reduced EPSP 
slope by 43.25% ± 5.1, n=4 and reduced EPSP slope by 17.48% ± 4.87, n= 4 
(P<0.001) and 14.15% ± 5.09, n=4 (P<0.001) in the presence of xanthine 100|iM. 
After changing stimulus to restore the potential size to the control level 
application of xanthine lOOjiM reduced response to adenosine significantly by 
24.07% ± 5.9, n=3, P<0.001 and 22.47% ± 4.97, n=3, P<0.001 compared to the 
control level (Fig. 3.53). The effect of adenosine on paired-pulses was also 
reduced significantly in the presence of xanthine after reducing stimulus strength 
(Fig. 3.54).
Adenosine response on single pulses and paired-pulses in the presence of xanthine 
oxidase 0.02 U/ml were also reduced significantly (20.14% ± 7.03, n=3, p<0.05) 
compared with adenosine alone that reduced EPSP slope by (48.04% ± 5.9, n=3). 
The first adenosine response did not change in the presence of xanthine oxidase 
(45.77% ± 6.34, n=3). Xanthine oxidase could not induce LTP in the slices (Fig. 
3.55 & Fig. 3.56).
Role o f guanylyl cyclase inhibitor and super oxide dismutase 
In order to determine whether guanylyl cyclase was involved in the effects of 
X/XO, the experiments with X/XO were repeated in the presence of the guanylyl 
cyclase inhibitor, ODQ.
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Interestingly, the guanylyl cyclase inhibitor ODQ 10p,M could prevent the 
inhibitory effects of X/XO on adenosine response (46.73% ± 5.33, n=4) and 
adenosine alone then reduced EPSP slope by 52.95% ± 3.56, n=4 (Fig.3.57). 
Application of superoxide dismutase (SOD) 120 U.mF^ (as shown with Klann et 
al., 1998) could prevent the inhibitory effect of xanthine/xanthine oxidase on the 
adenosine response. Adenosine alone suppressed EPSP slope by 52.95% ± 7.33, 
n=4 and it was 49.5% ± 6.99, n=4 and 51.5% ± 9.07 in the presence of 
xanthine/xanthine oxidase and SOD (Fig. 3.58).
SOD also prevents the induction of LTP and reduction of the inhibitory effect of 
xanthine on adenosine response. Adenosine alone suppressed EPSP slope by 
52.19% ± 6.51, n=3 and in the presence of xanthine and SOD by 46.9% ± 4.56, 
n=3 and 42.19% ± 6.16, n=3.
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Figure 3.53. Histogram showing the interaction between adenosine 10|iM and 
X100p,M on fEPSPs evoked from the CAl region of hippocampal slices. Each 
vertical bar represents mean ± S.E.M for n = 3 slices. ** P<0.01, *** P<0.001,
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Figure 3.54. Modulation of orthodromie evoked paired-pulse fEPSPs by 
adenosine 10|iM and xanthine lOOpM after reducing the stimulus to restore the 
potential size to control level. Each point represents mean ± S.E.M for n = 3 
slices. ** P<0.01 and *** P<0.001 control and adenosine, # P<0.05 between 
adenosine and adenosine + xanthine (first response), + P<0.05 between adenosine 
and adenosine + xanthine (second response).
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Figure 3.55. Histogram showing the interaction between adenosine lOpM and 
XO 0.02U.mr’ on fEPSPs evoked from the CAl region of hippocampal slices at 
normal stimulus strength. Each vertical bar represents mean ± S.E.M for n = 4 
slices. * P<0.05, *** P<0.001,
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Figure 3.56. Modulation of orthodromic evoked paired-pulse fEPSPs by
adenosine lOpM and XO O.OlU.ml"^ at normal stimulus strength. Each point
represents mean + S.E.M for n = 4 slices. * P<0.05, ** P<0.01 between control
and adenosine.
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Figure 3.57. Histogram showing the interaction between adenosine 10|iM and 
X100[xM/XO 0.02U.mr‘ in the presence of ODQ 10|xM on fEPSPs evoked from 
the CAl region of hippocampal slices at normal stimulus strength. Each vertical 
bar represents mean ± S.E.M for n = 4 slices. *** P<0.001,
129
Control
Adenosine 10pM
I W l  Adenosine 10pM+X 100p + XO 0.02U.ml"‘ + SOD 120U.ml"' 
PW1 X 100pM + XO 0.02U.mr^ + SOD 120U.ml"' 
r m  Adenosine 10pM +X100pM +X0 0.02U.ml VSOD 120U.mr
ns
120
100
80
I^  60
85&
40
20
ns
Figure 3.58. Histogram showing the interaction between adenosine lOpM and 
XlOOjiM/XO 0.02Umr' in the presence of SOD 120Umr^ on fEPSPs evoked 
from the CAl region of hippocampal slices at normal stimulus strength. Each 
vertical bar represents mean ± S.E.M for n = 4 slices. *** P<0.001
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D oes superoxide act via the generation o f NO?
It was of some surprise that the effects of superoxide produced by the X/XO 
mixture were prevented by ODQ, since there is little evidence that superoxide 
works via the activation of adenylate cyclase. We therefore assessed whether 
superoxide might act to suppress adenosine receptors indirectly, via the generation 
of NO.
The nitric oxide synthase inhibitor
When slices were superfused with the nitric oxide synthase inhibitor, N°-nitro-L- 
arginine methyl ester hydrochloride (L-NAME), the X/XO mixture was still able 
to inhibit responses to adenosine (Fig. 3.59). We also tested haemoglobin at 
50|xM, since this is well established as a scavenger of NO in solution. When 
superfused over the slices, haemoglobin prevented the reduction of adenosine 
responses by X/XO and also prevented the induction of LTP by X/XO (Fig. 3.60). 
Due to the formation of foam following perfusion of Hb, the antifoaming agent 
antifoam A was included at 50p.p.m during these experiments. This agent had no 
effect by itself on fEPSP slope.
NMDA receptors
Having established that NO and superoxide could both suppress sensitivity to 
adenosine selectively and via the activation of guanylate cyclase, we tested SOD 
and the guanylate cyclase inhibitor ODQ against the ability of NMDA to reduce 
adenosine responses. The superfusion of NMDA at 4)iM for 10 min had no 
significant effect itself on fEPSP size. When NMDA was applied before and 
during the application of adenosine 10p,M there was a significant suppression of 
the responses to adenosine (34.25% ± 3.65, n = 6, P < 0.05, compared with
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adenosine alone 54.43% ± 3.8, n = 6). The superfusion of ODQ at lOpM did not 
prevent the suppression of inhibitory adenosine responses by NMD A, which 1,:kremained significantly different from the responses to adenosine alone, but not f
'i
different from responses to adenosine in the presence of NMDA (Fig. 3.61) 
indicating that NO did not mediated the suppression effects of adenosine by 
NMDA receptors. SOD at 120U.mr^ had an intermediate, ambiguous effect.
There was no significant difference between the size of adenosine responses in the 
presence of NMDA and in the presence of NMDA plus SOD, suggesting a lack of 
effect. On the other hand, the adenosine responses in NMDA plus SOD were not 
significantly different from the control responses to adenosine alone (Fig. 3.62).
A diagram summarising all the results relating to the interaction between 
adenosine, NO and free radicals is given in figure 3.65.
Electrically-induced LTP
For comparison with the effects of exogenous NMDA, we also examined the 
effects of electrically induced LTP using a Is tetanus at lOOHz. Twenty minutes 
after electrical stimulation, LTP reached a level of 127.34% ± 5.13, (n = 5, P <
0.01). Adenosine induced a reduction of 54.92% ± 6.93 of fEPSP slope before 
induction of LTP, but 25 min after inducing LTP and adjusting stimulus strength 
to restore the potentiated responses to control size, adenosine reduced the 
responses by only 31.19% ± 5.81 (n = 5, P < 0.01) (Fig. 3.6). L-NAME was tested 
in a series of slices in which the electrically-induced LTP reached 126.76% ±9.53 
(n = 4, P < 0.05). L-NAME itself at lOOpM had no effect on fEPSP slope, but it 
prevented the reduction of adenosine responses by electrically-induced LTP (Fig.
3.64).
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Figure 3.59. Histogram showing the interaction between adenosine lOfiM and 
X100|iM/XO 0.02Umr* in the presence of L-NAME lOOp-M on fEPSPs evoked 
from the CAl region of hippocampal slices at normal stimulus strength. Each 
vertical bar represents mean ± S.E.M for n = 4 slices. *P<0.05, ** P<0.01, *** 
P<0.001
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Figure 3.60. Histogram showing the interaction between adenosine 10j.xM and 
X lOOjiM/XO 0.02Umr* in the presence of haemoglobin 50p,M on fEPSPs 
evoked from the CAl region of hippocampal slices at normal stimulus strength. 
Each vertical bar represents mean ± S.E.M for n = 4 slices.
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Figure 3.61. Histogram showing the interaction between adenosine lOjiM and 
NMDA 4p.M in the presence of guanylyl cyclase inhibitor ODQ 10p,M on fEPSPs 
evoked from the CAl region of hippocampal slices at normal stimulus strength. 
Each vertical bar represents mean ± S.E.M for n = 4 slices. *P<0.05, *** P<0.001
135
Control
Adenosine 10|xM
R m  NMDA 4pM
12WI Adenosine lO i^M + NMDA 4pM 
11 I II Adenosine 10|xM+ NMDA 4 |lIM+ SOD 120U.mr^
ns
120
100
80
% 60
40
20
Figure 3.62. Histogram showing the interaction between adenosine 10|iM and 
NMDA 4^iM in the presence of SOD 120U.ml'^ on fEPSPs evoked from the CAl 
region of hippocampal slices at normal stimulus strength. Each vertical bar 
represents mean ± S.E.M for n = 4 slices. *P<0.05, *** P<0.001
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Figure 3.63. Histogram showing the effects of adenosine 10|liM after reducing the 
stimulus to control level following induction of electrical LTP on population spike 
evoked from the CAl region of hippocampal slices at normal stimulus strength. 
Each vertical bar represents mean ± S.E.M for n = 4 slices. ** P<0.01, *** 
P<0.001
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Figure 3.64. Histogram showing the effects of adenosine 10|liM after reducing the 
stimulus to control level following induction of electrical LTP in the presence of 
L-NAME 100|liM on population spike evoked from the CAl region of 
hippocampal slices at normal stimulus strength. Each vertical bar represents mean 
± S.E.M for n = 4 slices. * P<0.05, *** P<0.001
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Figure 3.65. This diagram illustrates the pathways investigated in this study on
the interaction between adenosine and NO, and adenosine and other free radicals
(superoxide). The possible mechanism of the effects of NO and superoxide on
suppression of adenosine effects by NMDA is also investigated.
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.4. Discussion
Interactions between adenosine and metabotropic glutamate receptors
Glutamate has been recognized as the major excitatory neurotransmitter within the 
mammalian CNS playing critical roles in brain function (Conn & Pin, 1997; 
Nakanishi et al., 1998). As result of its excitatory actions, glutamate can also 
modulate the release of various other neurotransmitters from synaptic terminals. 
The synaptic functions of glutamate are mediated through both ionotropic 
receptors and G protein-coupled metabotropic glutamate receptors. This study has 
considered the roles of metabotropic glutamate receptors in the modulation of 
adenosine receptors.
It is now well established that adenosine acts on presynaptic Ai receptors to 
depress neurotransmitter release, and that this action underlies its ability to 
depress transmission in the Schaffer-collateral to CAl synapses. Several previous 
studies have examined interactions between the ionotropic N-methyl-D-aspartate 
(NMDA) receptors and adenosine receptors (Bartrup & Stone, 1990; de 
Mendonca et al. 1995; Norenberg et al. 1997; Nikbakht & Stone, 2001), but 
interactions with metabotropic glutamate receptors have received relatively 
limited attention. Activation of mGluR2 receptors reduces the release of 
adenosine from brain slices (Casabona et al. 1994), and the non-selective agonist 
ACPD has been shown to inhibit the reduction by adenosine of glutamate release 
from cortical synaptosomes (Budd & Nicholls, 1995). Metabotropic glutamate 
receptors can also potentiate the activation of adenylate cyclase by adenosine A2A 
receptors (Alexander et al. 1992; Winder & Conn, 1993; Schoepp & Johnson,
•A
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1993). In a previous electrophysiological study it was noted that DHPG could 
depress the inhibitory activity of CPA in hippocampal slices (de Mendonca &
Ribeiro, 1997), but the site and mechanism of action were not investigated in
'I
detail. I
ClariHcation of the adenosine receptor
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In the present study we have confirmed that ACPD and the group I agonist DHPG 
depress the inhibitory effects of adenosine and CPA (de Mendonca & Ribeiro, 
1997). In principle, however, this apparent antagonism could result from an 
inhibition of the inhibitory Ai receptor responses, or a facilitation of the excitatory 
adenosine A2 A receptor responses generated by endogenous levels of adenosine. 
Such a facilitation has been demonstrated in other studies: the unilateral activation 
of striatal mGluRs by ACPD produces contralateral rotation which appears to be 
mediated in part by the activation of adenosine A2A receptors since agonists 
enhance, and selective antagonists suppress, the turning (Kearney & Albin, 1995). 
A synergistic interaction has also been described between adenosine A2 A receptors 
and metabotropic glutamate receptors in elevating cyclic AMP levels (Alexander 
et al. 1992; Winder & Conn, 1993; Schoepp & Johnson, 1993). The previous 
electrophysiological study of de Mendonca and Ribeiro (1997) did not clearly 
distinguish between these mechanisms, as endogenous adenosine was present in 
the slices which could have allowed either action to be superimposed on any 
direct interaction between metabotropic glutamate agonists and Ai receptors. In 
the present work, we have removed endogenous adenosine with adenosine 
deaminase, allowing us to conclude that the interaction is between group I
glutamate receptors and adenosine Ai receptors. We have also obtained further ;
Ievidence in support of this conclusion, with the demonstration that the A2A 
receptor blocker ZM241385 did not modify the ability of DHPG to suppress 
adenosine sensitivity.
I1
The effects of mGluR I agonists on hippocampal slices
%
Activation of group I mGluRs induces acute depression of fEPSP slope and LTD
:>
at CA3-CA1 synapses of the rat hippocampus. Whole-cell patch clamp (Manzoni 
& Bockaert, 1995) and analysis of paired-pulse facilitation experiments (Gereau 
& Conn, 1995; Faas et a l, 2002) have suggested a presynaptic calcium reduction 
for these effects. The specific mGluRl antagonist LY367385 suppressed acute 
depression of transmission induced by DHPG (Faas et a l, 2002; Shahraki &
Stone, 2002) whereas mGluR5 antagonist MPEP had no effect on EPSP 
depression induced by DHPG but completely prevented DHPG-induced LTD 
(Mannaioni et a l, 2001). These results indicate that the depression of transmitter
caused by DHPG is dependent on mGluRl activation whereas for mGluR-LTD |
ÏÏ
activation of mGluR5 is necessary in CAl region of hippocampus 
Three possible mechanisms might be involved in reduction of presynaptic calcium 
transients by group I mGluR activation: a) Direct blockade of voltage dependent 
calcium channels that might be mediated by reduced conductance, probability or 
open time, or number of active channels, b) Regulation of the ionic currents in the 
presynaptic action potential, causing a reduction in voltage dependent calcium 
channel activation, c) Decreased calcium release from intracellular stores (Faas et 
a l, 2002). d) Decreased sensitivity to calcium of the release process.
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Based on the results of Faas et ah, (2002) two distinct presynaptic mechanisms 
may be involved in DHPG- induced depression. The first one is reversible and 
involves mGLURl activation which reduces the stimulation-induced calcium 
transients. The second one mediates mGLUR-LTD by mGLURS activation which 
is based on downstream inhibition of presynaptic calcium influx.
Clarification of the metabotropic glutamate receptor
In the present work, both ACPD and DHPG themselves produced a significant 
depression of synaptic potentials. Inhibitory effects of ACPD on synaptic 
transmission have been reported in several brain regions and across species 
(Krieger et ah, 1996; King & Liu, 1996), including inhibition of synaptic 
transmission at the Schaffer collateral-CAl synapse (Gereau & Conn, 1995).
Both subtypes of group I receptor (mGluRi and mGluRg) are known to be present 
in the hippocampal CAl region. Many effects of group I agonists have been 
attributed to the mGluRg subtype, largely because of its presence in higher 
abundance in the CAl region (Lujan et ah, 1996), Immunocytochemical studies 
have revealed that group I mGluRs are located primarily on the postsynaptic sites, 
rather than presynaptically in the CAl area (Lujan et ah, 1996; Shigemoto et al. 
1997). However, functional evidence has indicated the presence of presynaptic 
group I mGluRs which increase intraterminal calcium levels and promote 
transmitter release (Croucher et ah, 2001; Schwartz & Alford, 2000). This 
paradox may be due to the postsynaptic receptor causing release of a retrograde 
messenger (Levenes et ah, 2001). While the use of selective ligands makes it clear 
that group I receptors are responsible for the interaction with adenosine (de
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Mendonca & Ribeiro, 1997; Shahraki & Stone 2002), we have now extended this 
observation by showing that the effects of DHPG upon adenosine sensitivity 
could be prevented by LY367385, an antagonist selective for the mGluia subtype 
(Mannaioni et ah, 2001), but not by SIB 1893 which is selective for the mGlug 
subtype (Varney et ah, 1999). We conclude that it is primarily the mGluia subtype 
which mediates the suppression of adenosine sensitivity, and our confidence in 
this conclusion is strengthened by our selection of drug concentrations. At the 
concentrations used here, both LY367385 and SIB 1893 have been shown to 
produce a greater than 50% blockade of responses mediated by mGluia and mGlug 
receptors in other experimental paradigms (Mannaioni et ah, 2001; Varney et ah 
1999).
Group I mGLUR selective agonists can activate phospholipase C and induce 
phosphoinositide hydrolysis, so producing inositol-1,4,5-trisphosphate (IP3) as 
well as diacylglycerol, which in turn activates protein kinase C. Activation of 
PKC could suppress the presynaptic inhibitory effects of adenosine in the 
hippocampus (Thompson et ah, 1992) and the neuromuscular junction (Sebastiao 
and Ribeiro, 1990). PKC is also able to decrease the inhibitory effect of the 
selective AI receptor agonist CPA on glutamate release in cerebrocortical 
synaptosomes (Budd & Nicholls, 1995).
Time course
In addition, it is apparent from the present data that the interaction between DHPG 
and adenosine receptors substantially outlasts the application of the glutamate 
receptor agonist. The reduction of adenosine sensitivity is apparent up to at least
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60 minutes after a 10 minute application of ACPD or DHPG, even though I
■I
baseline potential size is restored to control levels within minutes of the agonist 
application and remains so for at least 10 minutes until the next application of 
adenosine or CPA. This is consistent with biochemical studies that have reported 
effects of group I metabotropic receptor stimulation lasting more than 10 minutes 
(Budd & Nicholls, 1995) or up to 40 minutes (Alexander et al., 1992), and with a 
report of increased excitability of spinal neurons, and NMDA sensitivity lasting
up to 60 minutes (Budai & Larson, 1998). These observations emphasise that even 
transient increases in the extracellular levels of glutamate could produce long- 
lasting changes of neuronal excitability and synaptic transmission.
The long time course of action of ACPD and DHPG would also be consistent with 
the apparent mediation of the metabotropic receptor effects by protein kinase C 
(Shahraki & Stone 2003; de Mendonca & Ribeiro, 1997). A role for protein 
kinase C would be entirely consistent with previous demonstrations that the 
activation of protein kinase C is able to decrease the presynaptic inhibitory effects 
of adenosine in cerebrocortical synaptosomes (Budd & Nicholls, 1995), the 
hippocampus (Thompson et al., 1992) and neuromuscular junction (Sebastiao et 
ah, 1990).
Role of NMDA receptors
There are several indications that the activation of group I mGluRs can facilitate 
the activation of NMDA receptors (Fitzjohn et ah, 1996; Awad et ah, 2000; Salt & 
Binns, 2000; Attucci et ah 2001), probably mediated by protein kinase C (Pisani 
et ah 1997; Liao et ah, 2001). Since it has been shown that activation of NMDA
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receptors can reduce the inhibitory activity of adenosine (Bartrup & Stone, 1990; 
Nikbakht & Stone 2001), it was possible that the metabotropic receptor-mediated 
reduction of adenosine sensitivity was mediated indirectly by a facilitation of 
NMDA receptor activity. The results do indeed indicate that the mGluR / 
adenosine interaction could be prevented in the presence of the NMDA antagonist 
2AP5, making this a likely explanation.
Paired-pulse interaction, presynaptic mechanism and non-selectivity
Due to the small size of most nerve terminals, direct functional studies of 
synapses are difficult, so indirect methods can help researchers to study the 
control of neurotransmitter release. Paired-pulse stimulation is one of these 
methods that two stimuli are delivered at a short interval and a difference between 
the amplitudes of the first and the second responses is used to calculate a paired- 
pulse ratio (PPR). PPR is affected by neuromodulators or physiological conditions 
that change transmitter release probability. The following mechanisms affect the 
amplitude of an EPSP: a) the number of neurotransmitter release sites b) the 
probability of neurotransmitter release c) amplitude of the postsynaptic unit 
response at each release site. Paired-pulse facilitation is an inverse function of the 
initial probability of release related to the first pulse. If initial probability of 
release is high, indicating most terminals will release neurotransmitter in response 
to the first pulse, there will be little residual calcium, the probability of 
neurotransmitter release in response to the second stimulus will be reduced and 
PPF ratio will be small. In contrast, when the probability of neurotransmitter 
release is very low, few terminals will release in response to the first stimulus, and
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the enhanced residual calcium causes release of many more terminals in response 
to the second stimulus and PPF ratio will be high (Santschi & Stanton, 2003).
These explanations indicate that paired-pulse interaction is a presynaptic 
phenomenon rather than postsynaptic. The experiments of Debanne et al. (1996) 
revealed that paired-pulse interaction is not a postsynaptic mediated process I
because PPR remained unchanged following application of 6-cyano-7- 
nitroquinoxaline-2, 3-dione (CNQX) or receptor desensitisation with aniracetam.
When inhibitory synapses are activated by paired stimulation paired-pulse 
depression occurs because less transmitter is released by the second stimulus due 
to activation of GABAb autoreceptors in the CAl area (Davies et al., 1990) or 
because of transmitter depletion resulting from the first stimulus, as it has been 
observed in CA3 cells in the slice preparation (Lambert & Wilson, 1994) and at 
the inhibitory synapses in tissue culture (Wilcox & Dichter, 1994).
Depletion of the presynaptic readily releasable pool of synaptic vesicles has been 
proposed as the major component of PPD (Oleskevich et al., 2000; Meyer et al.,
2001). However, the role of other mechanisms such as presynaptic calcium 
channel inactivation (Gingrich & Byrne, 1985), negative feedback through 
inhibitory autoreceptors (Forsythe & Clements, 1990) or receptor desensitisation 
(Otis et al., 1996; Neher & Sakaba, 2001) cannot be excluded. Inactivation of 
presynaptic voltage-dependent sodium channels which may affect coupling of 
action potentials to transmitter release was recently proposed that contribute to 
PPD (Brody & Yue, 2000). He et al. (2001) showed that sodium channel 
inactivation was associated with EPSc depression under depolarising 
physiological or pathophysiological conditions.
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An important finding in the present study is that the depressant effect of group I 
agonists is not selective for adenosine Ai receptors, but is also exerted against the 
G A B A b receptor agonist, baclofen. This raises the possibility that the group I 
effects may not result from interactions at the receptor level, but are due to 
generalised changes in presynaptic terminal excitability or release processes. Such 
a mechanism would be consistent with the mediation of these effects by protein 
kinase C, which would be expected to modify transmitter release more generally 
than in response to only a single species of presynaptic receptor. Indeed, although 
relatively little work has been performed on functional aspects of group I 
metabotropic receptors on synaptic terminals, Schwartz & Alford (2000) and 
Croucher et al. (2001) have concluded that group I receptors on presynaptic 
terminals can increase glutamate release. The effects of group I agonists may not, 
therefore, indicate a selective interaction between metabotropic glutamate 
receptors and adenosine receptors, but may simply be the result of a non-specific 
antagonism of any agent with a tendency to suppress transmitter release. It should 
be emphasised, however, that the interaction with baclofen was less clear than 
with adenosine. Firstly, the responses to baclofen always recovered to control 
levels before 60 minutes following the glutamate receptor agonist and, secondly, 
the tendency to depress baclofen’s actions on paired-pulse phenomena often did 
not reach statistical significance.
The preceding discussion is based on the assumption that the interactions between 
the group I agonists and adenosine or baclofen are mediated at a common, 
presumably presynaptic site. Our use of paired-pulse interactions confirms that 
this is so. Particulaiiy when studied on EPSPs, the paired-pulse paradigm
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represents a valuable means of assessing the actions of compounds on presynaptic 
terminals. The paired-pulse inhibition obtained at interpulse intervals of 10 ms 
results from the depletion of transmitter from presynaptic stores (Burke & Hablitz, 
1994; Wilcox & Dichter, 1994; Hashimoto & Kano, 1998), and is reduced by 
agents or procedures which decrease transmitter release. Paired-pulse facilitation, 
observed at longer interpulse intervals, is due to the residual intraterminal Ca 
which increases transmitter release (Hess et al., 1987; Wu & Saggau, 1994b; 
Debanne et al., 1996; Kleschevnikov et al., 1997). The fact that the metabotropic 
glutamate receptor agonists can suppress the effects of adenosine in this system 
provides a strong argument that the interactions are occurring at presynaptic 
terminals. The present data do not, however, address the question as to whether 
the interaction between group I receptors and adenosine is a direct or indirect 
action. There is clear evidence that the activation of group 1 metabotropic 
receptors at postsynaptic sites can lead to the release of retrograde messenger that 
is responsible for at least part of the presynaptic effects of agonists (Levenes et al. 
2001; Maejima et al., 2001; Watabe et al., 2002). Only when there is a clear 
identification of the nature of such a messenger can its role in the depression of 
adenosine sensitivity be investigated further.
The activation of mGluRs can facilitate long-term potentiation, whereas 
antagonists inhibit it (Bortolotto et al. 1994; Petrozzino & Connor, 1994; Izumi et 
al. 2000). Cohen & Abraham (1996) reported that a single, 10 minute duration 
application of ACPD could produce a long-lasting enhancement of stimulation- 
induced LTP. The authors showed that this enhancement was not dependent on 
the activation of NMDA receptors, but did appear to involve group 1 mGluRs.
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Since the blockade of adenosine AI receptors by conventional antagonists is well 
known to facilitate LTP (de Mendonca & Ribeiro, 1994), it may be that the 
suppression of adenosine sensitivity could contribute to the reduction by ACPD of 
LTP threshold.
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Nitric oxide suppression of presynaptic responses to adenosine
The paired-pulse paradigm provides a valuable means of assessing the actions of 
compounds on presynaptic terminals. Paired-pulse inhibition at interpulse 
intervals of 10 ms reflects the depletion of transmitter from presynaptic stores 
(Burke & Hablitz, 1994; Wilcox & Dichter, 1994; Hashimoto & Kano, 1998), and 
is reduced by agents or procedures which decrease transmitter release (such as 
adenosine). Paired-pulse facilitation, observed at longer interpulse intervals 
around 20-50ms, is due to the residual intraterminal Ca^ "^  remaining after the first 
pulse and which facilitates subsequent transmitter release (Hess et al., 1987; Wu 
& Saggau, 1994; Debanne et al., 1996; Kleschevnikov et al., 1997). The present 
work has shown that the inhibitory actions of NO and superoxide on adenosine 
responses are reflected not only in changes of the fEPSP slope, but also in 
changes of these paired-pulse phenomena, strongly suggesting that the 
interactions between ROS and adenosine occur primarily at the presynaptic 
terminals. This is entirely in accord with a wealth of evidence that adenosine AI 
receptor-mediated actions are almost exclusively presynaptic in nature, including 
a recent study in which AI receptors were deleted selectively from CA3 or CAl 
neurons (Scammell et al. 2003).
Adenosine and NO
Adenosine is an endogenous purine that has an important role in the regulation of 
neuronal excitability and synaptic transmission in the hippocampus and which is 
able to modulate synaptic plasticity. Adenosine or its analogues inhibit LTP and 
LTD in hippocampal slices via adenosine AI receptors (de Mendonca & Ribeiro,
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1990, 2000; Arai et al., 1990; Kemp & Bashir, 1997; de Mendonca et al., 1997;
■I
Stone et al. 2003), partly by depressing transmitter release and partly by a direct
Iinhibitory action on NMDA receptors (de Mendonca et al., 1995). The modulation
Iof adenosine sensitivity is, therefore, a key factor in the control of network ;
excitability in the hippocampus and elsewhere.
The activation of NMDA receptors can suppress the inhibitory action of 
adenosine on synaptic transmission in hippocampal slices (Bartrup & Stone, 1988,
1990; Nikbakht & Stone, 2001), and we have now explored the possible 
involvement of NO in this interaction. The observation that administration of the 
NO donor SNAP to hippocampal slices resulted in the induction of LTP is 
consistent with previous reports of the induction or facilitation of LTP (Zhou et 
al., 1994; Malen & Chapman, 1997; Bon & Garthwaite, 2001) and of the 
involvement of NO in electrically-induced LTP (Doyle et al. 1996). In addition,
SNAP reduced the size of the inhibitory responses to adenosine. Even when the 
NO-induced LTP effect was cancelled by a compensatory reduction of stimulus 
strength, which reduced the increased potential size to that at the start of the 
experiment, adenosine responses remained suppressed. It could be argued that a 
reduction of stimulus strength is only a limited control procedure, since the 
biochemical consequences of inducing LTP may still be active. However, this 
procedure does at least allow a distinction between the effects of NO on 
sensitivity to adenosine and to baclofen, responses to the latter being unaffected 
by SNAP after this adjustment of stimulus strength, and indicating, whatever the 
underlying mechanisms, some specificity in the interaction between NO and 
adenosine responses.
L:; is - .
The NO-induced LTP is not attributable to its inhibition of adenosine sensitivity 
since adenosine deaminase did not produce LTP in these slices, and even in its 
presence, NO was still capable of generating normal LTP. Neither is the NO- 
induced LTP dependent on NMDA receptors, since it was not impaired by 2AP5 
as reported by Zhou et al., (1994) and Malen and Chapman (1997). Similarly, 
NMDA receptor activation does not appear to be instrumental in the inhibition by 
NO of responses to adenosine.
Superoxide
The activation of NMDA receptors can generate superoxide anions (Palumbo et 
al., 1992). Superoxide anions are also generated during the induction of LTP 
(Bindokas et al., 1996; Klann et al., 1998; Knapp & Klann, 2002), and their 
application to hippocampal slices induces LTP (Knapp & Klann, 2002). 
Conversely, the removal of superoxide by SOD impairs the induction of LTP 
(Gahtan et ah, 1998; Thiels et al., 2000). Indeed, the fact that lipoxygenase 
activity can generate superoxide (Kukreja et ah, 1986) and its inhibition can 
prevent LTP has led some to postulate a physiological role for superoxide in LTP 
(Lynch et ah, 1989; Klann, 1998). We have, therefore, examined whether 
superoxide could modify adenosine responses.
Application of X/XO - a known source of superoxide - could induce LTP of 
evoked fEPSPs. Confirmation for the involvement of superoxide was provided by 
the blockade of the LTP by SOD. Superoxide was also able to suppress the 
inhibitory activity of adenosine. Interestingly, both actions were prevented, as was 
the activity of NO, by the guanylate cyclase inhibitor, ODQ, suggesting that the
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actions of NO and superoxide are both mediated through cyclic GMP. Cyclic 
GMP activates cyclic GMP-dependent protein kinase C that has been proposed to 
play a role in induction of LTP by NO (Hawkins, et al., 1998; Calabresi, et al., 
2000).
Since there is little direct evidence in the literature for an action of superoxide on 
guanylate cyclase, we considered whether this anion could induce the production 
of NO as a mediator of its effects on the cyclase. The NO-scavenger haemoglobin 
did prevent the actions of X/XO, both on LTP and the suppression of adenosine 
responses, but the NO synthase inhibitor L-NAME had no effect. These data may 
indicate that superoxide facilitates the formation of NO via the non-enzymic route 
described by Zweier et al. (1995) or that Hb interacts directly with X/XO 
(Sadrzadeh et ah, 1984).
It was also of interest that xanthine itself could generate LTP and block the effects 
of adenosine. This did not appear to be a simple blockade of adenosine receptors, 
as it could be prevented by SOD. It is likely, therefore, that xanthine interacts with 
endogenous XO within the slices to generate ROS.
It has been suggested that free radicals can induce the release of excitatory amino 
acids in hippocampal slices (Pellegrini-Giampietro et al. 1988; Dawson et al., 
1993; Gilman et al. 1994). The ability of ROS to suppress the inhibitory effects of 
adenosine could contribute significantly to this action by blocking presynaptic 
inhibitory adenosine receptors on glutamate-releasing terminals. Conversely, an 
enhancement of glutamate release, acting via NMDA receptors might contribute 
to the suppression of the inhibitory effects of adenosine by SNAP or X/XO 
(Nikbakht & Stone 2001).
"1*
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Since the hypothesis which triggered this study was that the inhibition of 
adenosine responses by NMDA was mediated by NO, we performed a more direct 
test of the hypothesis using SOD and ODQ. We were able to confirm our earlier 
report that NMDA does indeed depress the inhibitory activity of adenosine but, 
whereas the inhibitory action of NMDA could be prevented by SOD, it was not 
convincingly prevented by guanylate cyclase inhibition which blocked the effects 
of both NO and X/XO. This could indicate that a different species of free radical, 
other than superoxide or NO, mediates the effect of NMDA on adenosine 
responses, perhaps acting independently of guanylate cyclase, or acting at a point 
between receptor activation and the enzyme. In contrast, the reduction of 
adenosine responses which follows the induction of LTP by electrical stimulation 
was prevented by L-NAME, implying that NO mediates this effect.
In summary, these data indicate that radical species such as NO and superoxide 
can suppress the inhibitory activity of adenosine at presynaptic sites, although 
neither of these radical species can fully account for the reduction of adenosine 
responses by NMDA. In contrast, electrically-induced LTP reduces sensitivity to 
adenosine via the generation of NO. The suppression of presynaptic adenosine 
responses may contribute to the injurious effects of free radicals in the CNS.
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5. General discussion
Adenosine can inhibit or enhance neuronal responses by operating G-protein 
coupled receptors. Interactions between adenosine receptors and other G-protein 
coupled receptors and ionotropic receptors might be involved in a fine-tuning of 
neuronal activity. The main purpose of this study was to explore the interactions 
between adenosine and metabotropic glutamate receptors, nitric oxide and free
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radicals in the CAl region of the hippocampus. We have extended earlier studies |
of the interactions between metabotropic glutamate receptors and adenosine 
receptors (de Mendonca & Ribeiro, 1997) to show, firstly, that the suppression of 
adenosine sensitivity is explained by a selectively reduced responsiveness to Ai 
receptor stimulation, seen even in the absence of endogenous adenosine, and does 
not involve any facilitation of A%A adenosine receptors. In addition we have 
shown that this effect can be localised to presynaptic terminals. However, the 
present data do not address the question as to whether the interaction between 
group I mGLURs and adenosine is a direct or indirect action. There is clear 
evidence that activation of group I metabotropic receptors at postsynaptic sites 
can lead to the release of a retrograde messenger that is responsible for at least 
part of the presynaptic effects of agonists (Levenes et ah, 2001; Maejima et al.,
2001; Watabe et al., 2002). Figure 5.1 summarises all results obtained in this 
thesis and presents them in the form of a hypothetical scheme. Only when there is 
clear identification of the nature of such a messenger can its role in the depression 
of adenosine sensitivity be investigated further. The interaction is not specific for 
adenosine receptors, but applies also to a suppression of responses mediated by 
GABAb receptors. The glutamate receptor involved appears to be the mGluia
subtype and the action of the metabotropic receptor is mediated indirectly by 
activation or facilitation of NMD A receptors. The long duration of the changes 
induced by metabotropic glutamate receptor agonists implies that these 
interactions could play an important role in changes of synaptic function long 
after even transient increases of glutamate release in the CNS.
Reduction of the inhibitory effects of adenosine by activation of group I mGLURs 
might be involved in the pathophysiological situations such as hypoxia and 
ischemia that exhibit considerable release of both excitatory amino acids and 
adenosine. It seems that the excessive release of glutamate would control the 
neuroprotective properties of adenosine. These observations would be helpful for 
designing viable therapeutic strategies for treatment of neurological disorders. 
Group I metabotropic glutamate receptors antagonists or adenosine A1 receptor 
agonists attenuate the neuronal damage following brain injury, hypoxia or 
ischemia (Mukhin, et al., 1996).
Activation of NMDA receptors also suppresses neuronal responses to adenosine 
in hippocampal slices (Nikbakht & Stone, 2001). Since NMDA receptor 
activation leads to the generation of nitric oxide and superoxide, we have 
examined whether these can modify neuronal responses to adenosine and mediate 
the actions of NMDA. Nitric oxide is a physiological messenger in the central 
nervous system that is produced by activation of nitric oxide synthase. 
Pathological conditions such as hypoxia and ischemia leads to generation of NO 
and excessive NO becomes neurotoxic (Dawson et al., 1991). Nitric oxide is able 
to increase cellular calcium influx by opening the NMDA associated calcium 
channel, or augment excitatory amino acids by stimulating the release of both
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glutamate and aspartate and inhibiting glutamate uptake. A further mechanism by 
which excess NO formation may lead to neuronal death is energy depletion due to 
mitochondrial dysfunction, such that it is not able to produce ATP. The 
mechanism of this dysfunction is not fully revealed but it has been suggested lack 
of mitochondrial respiration, swelling and increase in lipolysis of the
Jmitochondrial membrane may be involved in this condition (Bolanos et al., 1997).
An additional indirect mechanism by which NO may cause damage is depletion of ; .
the toxic molecule scavenger glutathione, through the formation of intracellular S- 
nitrosoglutathione. =
Our findings indicate that radical species such as NO and superoxide can suppress 
the inhibitory activity of adenosine at presynaptic sites, although neither of these t
radical species can fully account for the reduction of adenosine responses by 
NMDA. In contrast, electrically induced LTP reduces sensitivity to adenosine via
the generation of NO. The suppression of presynaptic adenosine responses may j
;contribute to the injurious effects of free radicals in the CNS. This may represent 
one mechanism by which adenosine exerts its neuroprotective effect. The effects
Iof adenosine on neuroprotection are exerted not only by promoting vasodilatation 
but possibly also by its neuromodulatory activities. Adenosine inhibits release of
!
neurotransmitters presynaptically by inhibiting adenylate cyclase, opening ^
channels and closing Ca^^ channels. Synaptic transmission is under control of 
endogenous extracellular adenosine with pre and postsynaptic interactions with 
other neuromodulators. The most frequent consequence of this interplay is 
neuronal protection through A1 receptor activation, but in some cases, A2A-
■■■ ■(
mediated increases in neuronal activity may be harmful and therefore Aia 
antagonism may be needed.
Application of X/XO - a known source of superoxide - could induce LTP of 
evoked fEPSPs and blockade of LTP with SOD supports its involvement in LTP. 
Superoxide was also able to suppress the inhibitory effects of adenosine. 
Interestingly, the guanylate cyclase inhibitor, ODQ, prevented both actions of 
X/XO and the activity of NO, suggesting that the actions of NO and superoxide 
are both mediated through cyclic GMP. Cyclic GMP activates cyclic GMP- 
dependent protein kinase C that has been proposed to play a role in induction of 
LTP by NO (Monfort, et al., 2002).
The NO-scavenger haemoglobin did prevent the actions of X/XO, both on LTP 
and the suppression of adenosine responses, while, the NO synthase inhibitor L- 
NAME had no effect. We assume that superoxide facilitates the formation of NO 
via the non-enzymic route (Zweier et al., 1995).
Overall this work has shown that presynaptic adenosine responses can be 
modulated by glutamate receptors and free radicals in way which may have 
important physiological and pharmacological relevance.
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-►  Previously known pathways
Steps demonstrated in this project
Figure. 5.1. This diagram represents the unknown pathways that have been found 
in this study on the interaction between adenosine and mGluRs, and interactions 
between adenosine and NO and free radicals in CA3-CA1 synapses in hippocampal 
slices.
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Future work
A numbers of suggestions for further experiments are proposed as follows:
a) Further evaluation of interaction between adenosine and NMDA
receptors to clarify which NMDA subunits are involved in the reduction of
adenosine responses.
b) Investigating the interaction between adenosine and group II and III 
mGluRs.
c) Investigating site of possible interactions between adenosine and group 
II and III mGluRs using paired-pulse experiments and recording of 
spontaneous miniature EPSPs using intracellular or patch clamp 
methods.
d) Further studies to investigate the effects of xanthine that itself induced 
LTP and reduction of adenosine responses, using application of 
xanthine oxidase inhibitors. Such results would show whether 
endogenous xanthine oxidase is responsible for the effects of xanthine 
or some other systems may be involved.
e) Searching for the pathways that produce enzyme-independent 
formation of NO.
f) Investigate the kinds of protein kinases that might be involved in the 
effects of NO and X/XO.
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